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Akademi University and the Finnish Foundation of Technology Promotion (TES) is 
gratefully acknowledged. 
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given me many opportunities to widen my scientific perspective by organizing 
seminars and courses within the broad field of chemical process engineering. In 
addition, it is has been valuable to have the possibility to present your own results to 
an audience which is not only from your narrow field of expertise. Furthermore, all the 
conference travelling support from GSCE is deeply acknowledged. 
This work has been performed under the supervision and with guidance from two 
inspiring scientists Prof. Mikko Hupa and Docent Leena Hupa. I feel that I have 
gotten lot of trust to work independently, but at the same time there has always been a 
safety net available. In addition, I want to thank you both for having given me endless 
possibilities to attend various courses and conferences, where I have had the 
opportunity to meet and network with the people behind the faceless journal articles. 
I would like to thank firstly Prof. Mikko Hupa for opening his office door to a 
young inexperienced technology student (without an appointment!) in 2006. This led 
via summer practice to a master thesis. I am grateful for the possibility to have been 
able to perform also my doctoral studies at the Laboratory of Inorganic Chemistry. I 
appreciate deeply your enthusiasm towards my work, and I admire your capability to 
always ask the right (but at the same time “irritating”) questions, which made me every 
time take one step further. Thank you.  
My day-to-day supervisor Docent Leena Hupa is profoundly acknowledged for her 
never-ending enthusiasm towards and knowledge of glass. You have given me the 
most important asset for performing this doctoral work, i.e. interest toward glass 
science. Glass is beautiful, is it not? Your door has always been open, and you have at 
all times been ready to comment the latest results; to teach to write manuscripts, 
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rebuttals, and conference presentations, but most importantly encouraged to try, try, 
and try again after the “not-so-successful-days” in the lab. 
No man is an island. When working with my doctoral thesis I have gotten an 
endless amount of help and support from a vast number of people. A special thank 
you goes to my co-authors Mr. Paul Ek, Dr. Jonathan Massera, and Dr. Niko Moritz. 
The collaboration with Dr. Fredrik Ollila from Bonalive Ltd. and Dr. Jukka Tuominen 
and Mr. Timo Lehtonen from Vivoxid Ltd. is kindly acknowledged. In early 2011, I 
had the possibility to visit the Nanyang Technological University in Singapore. I wish 
to extend my thanks to Prof. Subbu S. Venkatraman and Prof. Sam Zhang for giving 
me this great opportunity to visit the university. During my time in Singapore, I 
learned to put things in different perspectives and to ask questions beginning with 
‘why’. 
The Laboratory of Inorganic Chemistry (OOK) at Åbo Akademi University has a 
long background in glass science and has produced many great alumni. I have been 
privileged to learn from all the bits and pieces of information which you have left 
behind. Especially, all the priceless practical advice and encouragement from Dr. 
Hanna Arstila, Dr. Linda Fröberg, Dr. Minna Piispanen, Mr. Erik Vedel, and Dr. Di 
Zhang are deeply acknowledged. Thank you! I feel like a “kid sister in science”. 
During my doctoral studies, I have also had a possibility to work with a number of 
great “junior scientists”. Thank you all for all the fun moments and the tricky questions 
you made! A very warm and humble thank you goes to Ms. Jaana Paananen. You have 
taught and helped me so much in the lab. You are a true diamond. For the gentlemen 
from the “other side” of the material group, i.e. electrochemistry, I just want to say 
thank you for everything! Without you, the mornings would have been much grayer 
and the number of my fingers would not match ten. Mr. Linus Silvander is 
acknowledged for operating the SEM and for the “service” with a smile. All the 
practical help with ICP-OES measurements from Mr. Sten Lindholm is highly 
appreciated. The gentlemen in the “ion hunt” lab, Mr. Stig-Göran Huldén and Mr. 
Berndt Södergård, thank you for always been ready to brainstorm and answer my 
endless questions. Often, though, you created more questions by answering one… 
I want to thank all the members of OOK! Warm thanks goes also to all the people 
in the group for taking care of the “invisible” every day practicalities, making life so 
care-free at the office and the lab, but especially thank you Eva, Kaj, Maria, Mia, Pettu, 
and Peter. A warm hug with a smile goes to all the wonderful dear friends from all 
over the world who I have had opportunity to meet during the course of this thesis. 
Thank you for sharing all the laughter and tears!  Especially, “Pikku-Leena” thank you 
for making the final stage of writing this thesis so much more fun! 
Life is not only about work. A huge hug goes to my all dear friends who have 
always been around believing in me and encouraged to strive towards my dreams. You 
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letters says it all: JÄD! 
 
Turku, October 2012 
 
 
Susanne Fagerlund 
 
 
 
 
 
 
  
 IV 
Abstract  
Glass is a unique material with a long history. Several glass products are used daily in 
our everyday life, often unnoticed. Glass can be found not only in obvious applications 
such as tableware, windows, and light bulbs, but also in tennis rackets, windmill turbine 
blades, optical devices, and medical implants. The glasses used at present as implants 
are inorganic silica-based melt-derived compositions mainly for hard-tissue repair as 
bone graft substitute in dentistry and orthopedics. The degree of glass reactivity 
desired varies according to implantation situation and it is vital that the ion release 
from any glasses used in medical applications is controlled. 
Understanding the in vitro dissolution rate of glasses provides a first approximation 
of their behavior in vivo. Specific studies concerning dissolution properties of bioactive 
glasses have been relatively scarce and mostly concentrated to static condition studies. 
The motivation behind this work was to develop a simple and accurate method for 
quantifying the in vitro dissolution rate of highly different types of glass compositions 
with interest for future clinical applications. By combining information from various 
experimental conditions, a better knowledge of glass dissolution and the suitability of 
different glasses for different medical applications can be obtained. Thus, two 
traditional and one novel approach were utilized in this thesis to study glass 
dissolution. 
The chemical durability of silicate glasses was tested in water and TRIS-buffered 
solution at static and dynamic conditions. The traditional in vitro testing with a TRIS-
buffered solution under static conditions works well with bioactive or with readily 
dissolving glasses, and it is easy to follow the ion dissolution reactions. However, in the 
buffered solution no marked differences between the more durable glasses were 
observed. The hydrolytic resistance of the glasses was studied using the standard 
procedure ISO 719. The relative scale given by the standard failed to provide any 
relevant information when bioactive glasses were studied. However, the clear 
differences in the hydrolytic resistance values imply that the method could be used as a 
rapid test to get an overall idea of the biodegradability of glasses. The standard method 
combined with the ion concentration and pH measurements gives a better estimate of 
the hydrolytic resistance because of the high silicon amount released from a glass. 
A sensitive on-line analysis method utilizing inductively coupled plasma optical 
emission spectrometer and a flow-through micro-volume pH electrode was developed 
to study the initial dissolution of biocompatible glasses. This approach was found 
suitable for compositions within a large range of chemical durability. With this 
approach, the initial dissolution of all ions could be measured simultaneously and 
quantitatively, which gave a good overall idea of the initial dissolution rates for the 
individual ions and the dissolution mechanism. These types of results with glass 
dissolution were presented for the first time during the course of writing this thesis. 
Based on the initial dissolution patterns obtained with the novel approach using TRIS, 
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the experimental glasses could be divided into four distinct categories. The initial 
dissolution patterns of glasses correlated well with the anticipated bioactivity. 
Moreover, the normalized surface-specific mass loss rates and the different in vivo 
models and the actual in vivo data correlated well. The results suggest that this type of 
approach can be used for prescreening the suitability of novel glass compositions for 
future clinical applications. Furthermore, the results shed light on the possible 
bioactivity of glasses. 
An additional goal in this thesis was to gain insight into the phase changes 
occurring during various heat treatments of glasses with three selected compositions. 
Engineering-type T-T-T curves for glasses 1-98 and 13-93 were established. The 
information gained is essential in manufacturing amorphous porous implants or for 
drawing of continuous fibers of the glasses. Although both glasses can be hot worked 
to amorphous products at carefully controlled conditions, 1-98 showed one magnitude 
greater nucleation and crystal growth rate than 13-93. Thus, 13-93 is better suited than 
1-98 for working processes which require long residence times at high temperatures. 
It was also shown that amorphous and partially crystalline porous implants can be 
sintered from bioactive glass S53P4. Surface crystallization of S53P4, forming 
Na2O∙CaO∙2SiO2, was observed to start at 650°C. The secondary crystals of 
Na2Ca4(PO4)2SiO4, reported for the first time in this thesis, were detected at higher 
temperatures, from 850°C to 1000°C. The crystal phases formed affected the 
dissolution behavior of the implants in simulated body fluid. This study opens up new 
possibilities for using S53P4 to manufacture various structures, while tailoring their 
bioactivity by controlling the proportions of the different phases. 
The results obtained in this thesis give valuable additional information and tools to 
the state of the art for designing glasses with respect to future clinical applications. 
With the knowledge gained we can identify different dissolution patters and use this 
information to improve the tuning of glass compositions. In addition, the novel on-
line analysis approach provides an excellent opportunity to further enhance our 
knowledge of glass behavior in simulated body conditions. 
Keywords: glass, in vitro, dissolution, continuous measurement, ICP-OES, 
crystallization 
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Svensk sammanfattning 
Glas är ett unikt material med en lång historia.  Produkter av glas används dagligen i 
ett flertal olika syften, ofta utan att man tänker på det. Glas förekommer således inte 
enbart i uppenbara föremål som kärl, fönster och lampor, utan även i t.ex. 
tennisracketar, turbinblad för vindkraftverk, optiska instrument och medicinska 
implantat. Dagens medicinska glass implantat består av olika oorganiska 
kiseloxidbaserade smälthärledda sammansättningar och de används huvudsakligen för 
hårdvävnadsreparationer, dvs. som bentransplantatsubstitut inom tandvård och 
ortopedi.  Beroende på användningsändamål är det nödvändigt att glas av olika 
reaktivitet tillämpas och det är ytterst viktigt att jonfrisättningen från samtliga glas som 
används i medicinskt syfte kontrolleras. 
Iakttagelser av glasets upplösningshastighet ”in vitro” ger en första approximation 
av hur glas beter sig ”in vivo”. Forskningen av bioaktiva glas, med särskild fokus på 
upplösningsegenskaper har hittills varit relativt begränsad och mestadels baserad på 
undersökningar gjorda i statiska förhållanden. Ett av huvudsyftena med detta arbete är 
således att utveckla en enkel och exakt metod för att kvantifiera in vitro-
upplösningshastigheten för glas med mycket olika sammansättningar för eventuella 
framtida kliniska tillämpningar. Genom att föra samman information från olika 
experimentella förhållanden har kunskap om olika glas upplösning och deras 
lämplighet för olika medicinska tillämpningar erhållits. I detta arbete har alltså två 
traditionella och en ny metod kombinerats för att undersöka lösligheten av olika glas. 
Den kemiska hållbarheten hos silikatglas undersöktes i vatten och TRIS-buffrade 
lösningar i både statiska och dynamiska förhållanden. Den traditionella in vitro-
testmetoden som utnyttjar en TRIS-buffrad lösning under statiska förhållanden 
fungerar bra med bioaktiva och lättupplösliga glastyper, och det är enkelt att följa 
samtliga jonupplösningsreaktioner. Däremot gick det inte (med hjälp av denna metod) 
att särskilja mellan glas av mera hållbar natur. Det hydrolytiska motståndet hos olika 
glas studerades med hjälp av standardförfarandet ISO 719. Det gick inte att erhålla 
någon relevant information om bioaktiva glas med hjälp av den relativa skalan i 
standarden, men trots allt skulle de tydliga skillnaderna i de hydrolytiska 
resistansvärdena kunna innebära att metoden eventuellt kan användas som ett snabbt 
test för att skapa sig en uppfattning om den biologiska nedbrytbarheten av glaset i 
fråga. En kombination av standardmetoden tillsammans med jonkoncentrations- och 
pH-mätningar ger en bättre uppskattning av det hydrolytiska motståndet på grund av 
den höga mängden kisel som har frigjorts från glaset. 
En känslig online-analysmetod som utnyttjar en optisk emissionsspektrometer med 
induktivt kopplat plasma och en genomströmningsmikrovolymetrisk pH-elektrod har 
utvecklats för att studera den initiala upplösningen av biokompatibla glas. Detta 
tillvägagångssätt har visat sig lämpligt för att studera sammansättningar med ett brett 
spektrum av kemisk hållbarhet. Med denna metod kan den initiala upplösningen av alla 
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joner mätas samtidigt och kvantitativt, resulterande i en god första uppskattning av de 
initiala upplösningshastigheterna för de enskilda jonerna och den dominerande 
upplösningsmekanismen. Dessa slags glasupplösningsresultat presenterades första 
gången i samband med denna avhandling. Baserat på det initiala upplösningsbeteendet 
som erhölls med den nya metoden i en TRIS-lösning kunde de experimentella glasen 
delas in i fyra klasser. Formen på glasens olika initiala upplösningsprofiler korrelerade 
väl med den förväntade bioaktiviteten. Utöver detta korrelerade även den 
normaliserade ytspecifika massaförlusthastigheten för de olika in vivo-modellerna och 
faktiska in vivo-data väl. Resultaten tyder på att denna typ av tillvägagångssätt med 
fördel kan användas för preliminär kontroll av lämpligheten hos nya 
glassammansättningar i framtida kliniska tillämpningar. Dessutom ger metoden 
intressant information om glasens eventuella bioaktivitet. 
Ett ytterligare mål med denna avhandling var att få insikt i de fasförändringar som 
sker i tre specifika glassammansättningar under varierade värmebehandlingar. För två 
av dessa, 1-98 och 13-93, kunde praktiska T-T-T-kurvor fastställas. Denna information 
behövs vid tillverkningen av amorfa porösa implantat och dragandet av kontinuerliga 
fibrer av glas. Även om båda glasen kan värmebehandlas för att erhålla amorfa 
produkter under noggrant kontrollerade förhållanden, visade 1-98 en kärnbildning och 
kristalltillväxthastighet som var en storleksordning större än hos 13-93. Sålunda kan 
man konstatera att glas av typen 13-93 är bättre lämpad än 1-98 i produktionsprocesser 
som kräver långa uppehållstider i höga temperaturer. 
Det konstaterades också att amorfa och partiellt kristallina porösa implantat kan 
sintras från bioaktivt glas S53P4. Ytkristalliseringen av S53P4 i form av 
Na2O∙CaO∙2SiO2 observerades börja vid 650 °C. Sekundära kristaller av 
Na2Ca4(PO4)2SiO4, som första gången presenteras i denna avhandling, upptäcktes vid 
högre temperaturer mellan 850 °C och 1 000 °C. De kristallfaser som bildades 
påverkade upplösningsbeteendet hos implantatens upplösningsbeteende i simulerad 
kroppsvätska. Denna studie pekar på nya möjligheter att tillverka olika strukturer av 
S53P4, samtidigt som bioaktiviteten kan skräddarsys genom kontroll av den 
proportionella mängden av de olika faserna i glaset. 
De resultat som erhölls i denna avhandling ger värdefull kompletterande 
information samt verktyg för den senaste tekniken inom glasdesign när det gäller 
framtida kliniska tillämpningar. Med hjälp av denna information kan vi identifiera olika 
upplösningsbeteenden och därmed på ett bättre sätt finjustera glassammansättningen 
för olika ändamål. Dessutom ger den nya online-analysmetoden oss en utmärkt 
möjlighet att ytterligare förbättra vår kunskap om hur olika glas beter sig i simulerade 
kroppsförhållanden. 
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List of abbreviations and symbols 
Abbreviations:   
µCT Micro-computed tomography  
AES Atomic Emission Spectroscopy  
ASTM American Society of Testing Materials  
BAG Bioactive glass  
BO Bonding/bridging oxygen  
CaP Calcium phosphate  
CS Wollastonite, CaO·SiO2  
DIN German Institute for Standardization  
DTA Differential Thermal Analysis   
EDXA Energy Dispersive X-ray Analysis  
FDA U.S. Food and Drug Administration  
FTIR Fourier transform infrared spectroscopy  
HA Hydroxyapatite  
HGB Hydrolytic resistance classification  
HSM Hot stage microscopy  
HVG-DGG Hüttentechnische Vereinigung der Deutschen Glasindustrie e. V - 
Deutsche Glastechnische Gesellschaft e.V. 
 
ICG International Commission on Glass   
ICP Inductively coupled plasma  
ISO International Standard Organization  
ISO 719/P98 Glass – Hydrolytic resistance of glass grains at 98°C – Method of test 
and classification  
 
IUPAC International Union of Pure and Applied Chemistry  
JMA Johnson-Mehl-Avrami exponent  
LOD Limit of detection  
LOQ Limit of quantification  
MAS-NMR Magic-angle spinning nuclear magnetic resonance  
NA Not available  
NBO Non bonding oxygen  
NCS Sodium-calcium-silicate, xNa2O·yCaO·zSiO2  
NCS Sodium calcium silicate  
NLi normalized surface-specific mass loss of element i  
NRi normalized surface-specific mass loss rate of element i  
OES Optical Emission Spectroscopy  
p.a. pro analysi, purity grade. Products with a guarantee certificate and/or 
suitable for the stated analytical application 
 
PBS Phosphate buffered solution  
PCC Process Chemistry Centre  
PDF Powder diffraction file  
pKa Logarithmic acid dissociation constant  
ppb Parts per billion (109), µg/l  
ppm Parts per million (106), mg/l  
Qn Local configuration around each silicon atom where n is the number of 
bridging oxygen ranging from 0 to 4 
 
RN Reaction number  
RT Room temperature  
SA Surface area  
SA/V Surface area volume ratio  
SBF Simulated body fluid  
SEM Scanning electron microscope  
Si+CaP Mixed layer containing both silica and calcium phosphate  
SLG Soda lime glass(es)/float glass(es)  
   
 IX 
TRIS tris(hydroxymethyl)aminomethane (IUPAC: 2-Amino-2-
hydroxymethyl-propane-1,3-diol) or a solution buffered with it 
 
T-T-T Time-Temperature-Transformation   
TUT Tampere University of Technology  
Vsol Volume of the immersion solution  
wt% weight %  
XRD X-ray diffraction  
ÅA Åbo Akademi University  
   
Symbols:   
µ fluid viscosity  
ci concentration of element i  
D diffusivity  
Dp average particle diameter   
Ea,i apparent activation energy for element i (J/mol)  
F flow rate  
fi mass fraction of element i  
G superficial mass velocity based on the empty chamber cross section  
K constant  
M mol/l  
M mass  
N number of samples  
Ø diameter  
R gas constant 8.314 J/(mol·K)  
Re’ modified Reynolds number for backed beds  
SA surface area  
T temperature  
T time  
Tg glass transition temperature  
Tl liquidus temperature  
Tn max temperature of maximum nucleation  
Uaverage average crystal growth rate  
V volume  
Vsol volume of the immersion solution  
X crystal layer thickness  
Β buffer capacity  
λ wavelength  
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1. Introduction 
1.1. Glass – applications from tableware to medical implants 
Glass is a unique material with a long history, and it has even been quoted as an 
“indispensable and brilliant material for better life” [1]. To emphasize this, a few major 
milestones from the history of glass are presented in the time line in Figure 1, together 
with some ideas of future glass technologies. Several glass products are used daily in 
our everyday life, often unnoticed. Glass can be found not only in obvious applications 
such as tableware, windows, and light bulbs, but also in tennis rackets, windmill turbine 
blades, optical devices, and medical implants. Because of the high energy demands of 
glass production, and ever tightening environmental regulations, it is likely that in the 
future the role of glass will more clearly change from commodity towards high-end 
technology [1-3]. 
 
Figure 1. Selected milestones of glass and future targets (data collected from [2-8]) 
As shown in the timeline, the time for converting glass innovations into production 
has shortened during the centuries. This is because more resources than ever are 
invested in innovation and product development, which is also indicated in the 
growing number of publications. A data search performed using SciFinder (April 11 
2012) shows that a vast number of scientific publications including the concept “glass” 
are produced every year (Inset graph in Figure 2). The height of the columns in 
Figure 2 indicates the total number of publications per year. Furthermore, as many 
new applications are based on established glass types, the time from idea to market will 
likely become even shorter in the future. Still, there are some limitations to how fast a 
new product can reach the final user. 
2600 B.C. Earliest actual dated glass (Syrian origin)
1500 B.C. Technique for making usable hollow ware
1200 B.C. Pressing glass into open moulds
100-20 B.C. Glass blowing invented; 
glass industrial revolution: from luxury to necessity
1200 Large scale glass industry in Venice (a protected monopoly)
1268 Eye glasses described
1600 Art of  cut glass developed
1612 First glass textbook L’Arte Vetraria by Neri;
begin of  the scientific approach in glass technology
c 1590 The first telescope lenses were made in Italy
→ Late 1700 production of  optical quality glasses
for telescopes and microscopes
1857 Sheet-drawing process patented: plate-glass 
→ 1913 Flat-glass machine for commercial 
operations
1881 Glass bulbs 
→ 1926 High speed automatic production of  glass 
light bulbs developed
20th century towards low cost-production -
developments in manufacturing technology
Ancient Glass Engineered  Glass Modern Glass 
Present 
Technology
Future 
Technology
~2020…
“Unbreakable” glass
Glass for  various solar driven applications
Glass with add-on functionalities
Bioactive porous nanocomposites (clinical trials)
Stem Cell Engineering
1966 Optical fibers developed
1967 Hypothesis of  bioactive glass
→ 1969 Discovery of  bioactive glass
→ 1976 Confirmation of  Bioglass® bone bonding
→ 1985 Bioglass ® Ossicular Reconstruction Prosthesis (MEP ®)
1975 Glass recycling became accepted;
environmental friendlier processes
→  2020 Energy and environmental friendly processes
1980 Glass insulation fibers in space shuttle  
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For example, when glass is intended to be used in medical applications, and 
especially as an implantable device, there is heavy legislation for protecting the end-
user, the patient. The most important single requirement for a glass implant is that it is 
biocompatible (term discussed further in chapter 2.1), i.e. that it generates the most 
appropriate beneficial cellular or tissue response in a specific situation [9]. All 
implantable devices must be proven safe for the intended applications with in vitro and 
in vivo experiments, and finally with clinical trials prior to final sales permission [10, 11]. 
Regulations concerning implantable glass products have been recently summarized by 
Lindgren et al. [12]. Therefore, we need to accept that even though research steps are 
advancing rapidly, it will still take time for novel products to enter the clinics. 
 
Figure 2. Number of scientific publications containing the term “bioactive glass” published per 
year, and the corresponding data for the term “glass” in the inset graph  (Data search April 11 
2012, source SciFinder®) 
Today, only a few commercial bioactive glass products are available for clinical use 
(presented shortly in chapter 1.1.3) even though the concept of using glass as an 
implant material dates back to the late 1960s [8] and the research around bioactive 
glasses has become increasingly active (c.f. Figure 2). The glasses used at present as 
implants are inorganic silica-based melt-derived compositions mainly for hard-tissue 
repair as bone graft substitute in dentistry and orthopedics. In general, an ideal bone 
graft substitute is one that promotes bone healing, is replaced by the healing bone, is 
easy to handle, is inexpensive, and is readily available [13]. The market for all synthetic 
bone substitutes is around €40 million solely in Europe, and it is expected to increase 
annually by 12% (original source www.frost.com data adopted from [14]). 
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The main driving force for the development of bone substitute materials has been 
to find an alternative for autologous bone harvesting, which is an invasive procedure 
causing pain, bleeding, and morbidity for the patient [13, 15, 16]. Furthermore, elderly 
or pediatric patients and patients with malignant disease create limitations for 
successful bone harvesting [17]. Roughly 2.2 million bone graft operations, with 
estimated costs of around €2 billion ([18] in [19]), are performed worldwide annually, 
out of which 90–95% still involve harvesting bone from the patient [17, 19]. The use 
of frozen allogenic bone, often femoral heads removed during hip replacement [20], is 
common practice in orthopedics [21]. In Turku, the availability of allograft bones 
improved when allograft bone banking was started in 1972 for clinical purposes [22, 
23]. There are, however, several problems related to allografts and xenografts, such as 
uncertain availability, viral and bacterial infections, and foreign body reactions [17, 21, 
23-25]. When a synthetic substitute is used, the number of invasive procedures is 
halved, and thus the risk of infection or other complications is reduced. Furthermore, 
the use of a synthetic substitute usually shortens operation time and reduces the need 
for a second surgery [13, 19]. Thus, savings for the patient and for society may be 
noteworthy: the total savings derives not only because of the reduced operational cost 
but also from the reduced time needed for postoperative rehabilitation.  
1.1.1. Bioactive glass 
The glasses used in bone repair have a capability to bond to bone because of their 
special oxide composition. The implanted glass gradually dissolves and promotes new 
bone growth [26]. The sequence of reactions leading to bone-bonding is more closely 
presented in chapter 2.2.3. The glasses showing bone-bonding are called bioactive 
glasses. As commented by Prof. Ylänen from the Department of Biomedical 
Engineering at Tampere University of Technology (TUT), “glass is an optimal biomaterial: 
it does the job and disappears” [27]. Even though this is not always the case and glass 
remnants of some compositions have been found after several years of implantation 
[25, 28], his comment aptly describes the key idea behind bioactive glasses.  
Bioactive glasses are in general osteoconductive and have antimicrobial properties 
[25]. Albeit their physical appearance (cf. Figure 4) resembles that of conventional 
soda-lime glass, their chemical compositions are highly different, and the same applies 
to their reactivity in contact with aqueous solutions. A general review of reactions 
occurring when glasses are in contact with aqueous solutions is given in 2.2.3. 
Furthermore, the dependence of glass durability and bioactivity on glass compositions 
is presented in 2.2.4. Bioactive glasses consist of elements that are naturally present in 
the human body. The first bioactive glasses were based on the Na2O-CaO-P2O5-SiO2 
oxide-system [29], and later, K2O-MgO-B2O3 were added to improve the hot-working 
properties of the glasses [30]. Other elements, such as Ag [31-33], Al [34], Cu [35], Sr 
[36, 37], and Zn [38], have also been included either directly to the glass structure or in 
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coatings on glass to further enhance the antibacterial properties and cell response of 
the glass [39, 40]. 
1.1.2. Towards optimal glass composition for each implantation 
In addition to the demands presented above, an ideal bone substitute material should 
be mechanically stable [13]. Glass is a brittle and rigid material and cannot be used as 
such for load-bearing applications. Furthermore, glass has limitations in terms of 
shaping and bending. 
In our group, significant effort has been placed on developing more versatile 
product forms (Figure 3), such as sintered glass bodies [41], sol-gel derived structures 
[42, 43], and thin fibers [44], which could then be used alone or in composite 
structures. However, the manufacturing of these product forms from bioactive glasses 
is challenging. The hot-working of glass is dependent on viscosity, which again is 
dependent on temperature and glass composition. Glass composition further affects 
devitrification behavior and liquidus temperature [45], which together with viscosity 
dictate the working range for a certain glass composition. For bioactive glasses 45S5 
(Bioglass®) and S53P4 (Bonalive®), the hot-working range is narrow and the forming 
operations limited. Therefore, these glasses are used clinically only as particulates or 
monoliths. Today, however, there are glass compositions which are simultaneously 
bioactive, as shown in vivo, and allow hot-working [46-48]. 
 
Figure 3. Versatile product forms manufactured from bioactive glasses with various methods ([42, 
43, 49-52], publication VI). 
The general research aim within our bioactive glass research group has been to 
improve the understanding of the various physical and chemical properties important 
for the wide range of applications of bioactive glasses. An essential part of the research 
has been related to understanding and modeling the different properties as function of 
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glass composition [41, 44, 53-57]. The work with bioactive glasses started at the 
Laboratory of Inorganic Chemistry at Åbo Akademi University already at the 
beginning of the 1980’s [58], and the group has been active in publishing since then. 
When a literature search is conducted with the terms ‘bioactive glass’, it can be noticed 
that 5–19% of the annual publications include Finnish contributions (Figure 2), out of 
which 7–100% include contributions from Åbo Akademi University. 
The literature on viscosity, devitrification, and hot-working properties of bioactive 
glasses has been reviewed and discussed in several theses published by our group [41, 
44, 54-56]. In this thesis, the discussion is mainly limited to new findings made in this 
work, and no separate literature review is given concerning the aforementioned 
subjects. 
Today, not only bioactive glass compositions, but also a range of other glass 
compositions are of interest to various clinical applications. Hence, the term 
biocompatible is often used in this thesis instead of the term bioactive. Recent shifts in 
attitudes and thinking around definitions in biomaterials are discussed in more detail in 
2.1, and the different desired glass dissolution behaviors when implanted in the body 
are described in 2.2. A considerable research effort by our group has been directed 
towards bioactivity and reactivity of various glass compositions and product forms [41, 
44, 53-57]. In this thesis, the relevant concepts concerning bioactivity are revisited, 
with emphasis on recent literature, in order to help the reader understand the novel 
findings discussed. 
1.1.3. Current trends 
One of the leading trends todays for industrial enterprises is to provide solutions to a 
specific problem rather than merely sell a product. This trend can be observed in 
companies ranging from the energy sector [59] to the biomaterial business [60]. One 
good example is shown in Figure 4, where product development has advanced from 
simply selling loose glass granules to a product combining glass particles with an easy-
to-use function (BonAlive® applicator). When the applicator is provided with 
instructions for surgical procedures, the total solution brings more precision to the 
user, and finally more safety to the patient. 
Most commercial clinical bioactive glass products are based on the U.S. Food and 
Drug Administration (FDA)-approved compositions 45S5 and S53P4. However, there 
are new compositions emerging in the market such as Stronbone, which gained CE 
Marking approval in EU in 2010 [61]. The first clinical bioactive glass products were 
solid plates (a device for replacing the bones of the middle ear, 1985) and cones (a 
device designed to support labial and lingual plates in natural tooth roots, 1988), but 
most current applications are based on particulates [8, 62]. 
The clinical products and applications of mainly Bioglass® 45S5 have been 
reviewed by Hench [8, 63, 64] and by Jones [65]. The applications range from non-load 
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bearing bone grafts to treatment of dentinal hypersensitivity with bioactive glass-
containing toothpastes. Recently, also the applications of bioactive glass granules 
(S53P4) in orthopedics and traumatology, in maxillofacial reconstruction, and dentistry 
have been summarized by Heikkilä [13] and Peltola and Aitasalo [25]. S53P4 granules 
have been successfully used in treatment of benign bone tumor, metaphyseal fractures, 
and osteomyelitis, in posterolateral spinal surgery, in frontal sinus obliteration, and in 
frontal bone reconstruction, among others. 
 
Figure 4. Bonalive® granules in a pouch package and the BonAlive® applicator with a shovel. 
Pictures provided by courtesy of BonAlive Biomaterials Ltd., copyright BonAlive Biomaterials 
Ltd. (2012) 
The full potential of bioactive glasses has not been realized yet [66]. There has been 
interest to broaden the surgical scope of bioactive glasses by developing implantable 
pastes and putties, which would be more easily moldable during the surgery [67, 68]. In 
addition, more complicated product forms such as continuous melt derived fibers [69-
72] and various types of scaffolds (e.g. [35, 73-77]) have been developed. Thin 
biocompatible glass fibers have been used in woven porous textile composite 
structures [78] and in dense biodegradable load-bearing composites [79, 80] together 
with organic polymers. Different types of scaffold structures for tissue engineering 
have lately aroused great interest. The goal with the scaffolds is to help the body’s own 
regenerative mechanisms to restore a damaged tissue into its original state. It is 
possible to design scaffolds with variable degradation rates to match the rate of tissue 
ingrowth and remodeling [73, 81]. Different methods for manufacturing tissue-
engineering scaffolds have been recently reviewed by Gerhardt and Boccaccini [76]. 
Also the antibacterial properties of bioactive glasses have been of interest [31, 33, 81-
86].  
A common factor for the function of the above mentioned product forms in the 
body is the increased need to understand and control ion dissolution from the glasses 
used to manufacture these. As a consequence, the need for new methods to quantify 
the ion dissolution has been emphasized. 
1.2. Motivation for the work 
Knowledge of both dissolution behavior and hot-working properties is of utmost 
importance when glasses are developed for different clinical applications. 
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Understanding the in vitro dissolution rate of glasses provides a first approximation of 
their behavior of in vivo. Specific studies concerning dissolution properties of bioactive 
glasses have been relatively scarce and mostly concentrated to static condition studies. 
There is no absolute index to provide a measure for chemical durability of glass [4]. 
Already in 1940, the need for a quantitative approach was recognized by Dooley and 
Parmelee: “From the standpoint of a strictly quantitative approach to the problem of measuring 
chemical durability of glass, there is need for (1) a method to measure the surface area of irregular 
shaped particles that is independent of their chemical composition and surface condition and (2) 
methods to measure the actual ions present in extracts from durability tests” [87]. 
The motivation behind this work was to develop a simple and accurate method to 
quantify the in vitro dissolution rate of highly different types of glass compositions with 
interest for future clinical applications. In addition, as information on hot-working 
properties is required for forming glass, and thus studies concentrating also on these 
issues were included in this thesis. 
1.3. Objective of the work 
The objective of this work was to increase the understanding of in vitro dissolution 
behavior of glasses directed towards clinical applications by using different 
experimental methods. With the gained knowledge we can identify different 
dissolution patters and use this information to improve the tuning of glass 
compositions. An additional goal was to shed light on the phase changes occurring 
during various heat treatments of glasses using three selected compositions. 
In short, the thesis aims: 
o to work out a reliable method for analyzing the in vitro dissolution 
rate of glasses and to increase knowledge of the dissolution 
behavior of glasses with a wide range of chemical composition by:  
o comparing the suitability of conventional methods for 
dissolution studies with bioactive glasses  
o introducing a novel experimental approach to obtain 
dissolution patterns and rates for dissolution of glasses in 
the initial stages of fluid contact in a flow environment  
o correlating the initial dissolution with the in vitro and in vivo 
bioactivity of the glasses, as suggested by 
phenomenological models and experimental findings 
established earlier  
o to increase knowledge about the crystallization behavior of 
selected glasses by: 
o establishing Time-Temperature-Transformation (T-T-T) 
curves relevant to heat-treatment parameter optimization 
obtained using differential thermal analysis and 
conventional heat-treatments 
- Introduction - 
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o studying sintering of implants with concurrent 
crystallization and the effect of phase transformation on in 
vitro reactivity 
1.4. List of publications 
This thesis is based on the following publications, given as appendices: 
I. Comparison of reactions of bioactive glasses in different aqueous 
solutions 
S. Fagerlund, L. Hupa, M. Hupa 
In: Narayan, R., Singh, M., McKittrick, J., editors, Advances in Bioceramics and 
Biotechnologies: Ceramic Transactions Volume 218, Wiley, 2010, pp.101-113  
ISBN: 978-0-470-90548-7 
II. Dissolution kinetics of bioactive glass by continuous measurement  
S. Fagerlund, P. Ek, L. Hupa, M. Hupa 
Journal of American Ceramic Society, Vol 95 (2012) 10, pp. 3130-3137 
DOI: 10.1111/j.1551-2916.2012.05374.x 
III. On determining chemical durability of glasses 
S. Fagerlund, P. Ek, M. Hupa, L. Hupa 
Glass Technology: European Journal of Glass Science and Technology, Part A, 
Vol. 51 (2010) 6, pp. 235-240 
IV. Dissolution patterns of biocompatible glasses in TRIS buffer 
S. Fagerlund, L. Hupa, M. Hupa 
Acta Biomaterialia, in press, corrected proof (2012) 
DOI: 10.1016/j.actbio.2012.08.051 
V. T-T-T behavior of bioactive glasses 1-98 and 13-93 
S.Fagerlund, J. Massera, M. Hupa, L. Hupa 
Journal of the European Ceramic Society, Vol 32 (2012) 11, pp. 2731-2738 
DOI: 10.1016/j.jeurceramsoc.2011.10.040 
VI. Phase composition and in vitro bioactivity of porous implants made of 
bioactive glass S53P4 
S. Fagerlund, J. Massera, N. Moritz, M. Hupa, L. Hupa 
Acta Biomaterialia, Vol 8 (2012) 6, pp. 2331-2339 
DOI: 10.1016/j.actbio.2012.03.011 
In this thesis, the Roman numerals I-VI are used to refer to these original publications. 
The original publications are reproduced with the kind permission of the respective 
copyright holders. 
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1.5. Contribution of the author 
The following describes the author’s contribution to the papers on which this thesis is 
based: 
I. The author participated in the experimental design of the study and was 
responsible for all the experimental work. The scanning electron 
microscope (SEM) analyses were done in collaboration with an SEM 
specialist. The author evaluated the results, wrote the first draft of the 
manuscript, and finalized it together with the co-authors. 
II. The author was responsible for the experimental design of the study and 
did the experimental work together with one of the co-authors (excl. BET 
measurements). The author evaluated the results, wrote the first draft of 
the manuscript, and finalized it together with the co-authors. 
III. The author was responsible for the experimental design of the study as well 
as for the experimental work. The SEM analyses were done in 
collaboration with an SEM specialist. The author evaluated the results, 
wrote the first draft of the manuscript, and finalized it together with the 
co-authors. 
IV. The author was responsible for the experimental design of the study as well 
as did all the experimental work. The presented hot stage microscopy 
(HSM) and differential thermal analysis (DTA) data were based on 
unpublished measurements done at the group. The SEM analyses were 
carried out in collaboration with an SEM specialist. The author evaluated 
the results, wrote the first draft of the manuscript, and finalized it together 
with the co-authors. 
V. The author was responsible for the experimental design of the study and 
for the sample preparation, the isothermal heat-treatments and analysis of 
the monoliths. The DTA part was performed by one of the co-authors, 
and all the SEM analyses were done in collaboration with an SEM 
specialist. The author evaluated the results related to the isothermal heat-
treatment, wrote the first draft of the manuscript, and finalized it together 
with the co-authors. 
VI. The author was responsible for the experimental design. The author did all 
the experimental work. The micro-computed tomography (µCT) and SEM 
measurements were done in collaboration with specialists. The author 
evaluated the results, wrote the first draft of the manuscript, and finalized it 
together with the co-authors. 
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1.6. List of related contributions 
The following list comprises results related to this thesis: 
 Liquidus Temperatures of Bioactive Glasses 
H. Arstila, M. Tukiainen, S. Taipale, M. Kellomäki, L. Hupa 
Advanced Materials Research, Vols. 39-40 (2008), pp. 287-292 
 Continuous Measurement of the Dissolution Rate of Ions from Glasses 
S. Taipale, P. Ek, M. Hupa, L. Hupa 
Advanced Materials Research, Vols. 39-40 (2008), pp 341-346 
 Crystallization of 45S5 during isothermal heat treatment 
S. Fagerlund, L. Hupa 
Materialy Ceramiczne/Ceramic Materials, Vol. 62 (2010) 3, pp. 349-354 
 Surface reactions of bioactive glasses in buffered solution 
L.Varila, S. Fagerlund, L. Hupa, T. Lehtonen, J. Tuominen 
Journal of the European Ceramic Society, Vol 32 11, pp. 2757-2763 
DOI: 10.1016/j.jeurceramsoc.2012.01.025 
 Crystallization mechanism of the bioactive glasses 45S5 and S53P4 
J. Massera, S. Fagerlund, L. Hupa, M. Hupa 
Journal of American Ceramic Society, Vol. 95 (2012) 2, pp. 607-613  
DOI: 10.1111/j.1551-2916.2011.05012.x 
1.7. Thesis organization 
This thesis consists of a summary part and six peer-reviewed publications. In chapter 2 
(literature review), the key concepts relevant to this thesis are presented, whereas 
chapter 3 (materials and methods) shortly summarizes the experimental details. The 
first four publications concentrate on the dissolution behavior of glasses while the last 
two have the main focus on the crystallization and sintering of glass. The key findings 
from each publication are discussed in chapter 4.  
Publication I describes the effect of the immersion solution to glass dissolution. 
Four known glass compositions were tested in vitro with three different buffered 
solutions. Publication II presents in detail the novel experimental approach used in this 
thesis and introduces the effect of selected experimental parameters on the initial glass 
dissolution by using one glass composition. In publication III, glass dissolution is 
studied using three different methods and five glasses with highly different anticipated 
chemical durability. The dissolution patterns of 16 biocompatible glasses in TRIS were 
recorded with the novel continuous method presented in publication II, and the results 
and findings are discussed in publication IV. The results from publications II–IV are 
dealt with together and discussed as an entity in this thesis. The crystallization behavior 
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of two bioactive glasses was studied in publication V, and engineering-type T-T-T 
curves were established. In publication VI, the crystallization and sintering of one 
bioactive glass composition was studied in detail. Furthermore, the dissolution 
behavior of the partially crystallized sintered structures was studied. 
The conclusions are presented in chapter 5 together with a short outlook for the 
future. In the appendix, a comprehensive list of definitions is given to clarify the 
terminology used in this thesis. The definitions in the biomaterial field come from a 
plethora of sources and are sometimes used in a somewhat “wild-west” manner, which 
may cause confusion in some cases. 
- Review of the literature - 
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2. Review of the literature 
2.1. Biocompatible materials - biomaterials 
Biomaterials are designed to improve human health and the quality of life by restoring 
the function of natural living tissue and organs in the body. Biomaterials can be 
divided into several subcategories by using material classifications [88], tissue-implant 
interactions [26], or life-length of the implant in the body [89]. 
The single most important factor for a biomaterial is that it is able to be in contact 
with tissues of the human body without causing an unacceptable degree of harm to 
that body [9], i.e. the material is biocompatible. Biocompatibility has been defined 
earlier (1986) simply as the “ability of a material to perform with an appropriate host response in 
a specific situation” ([90] in [9]). Even though this definition is valid for long-term 
implantable devices, it does not cover the ever wider range of different applications of 
biomaterials. Thus, a more detailed definition encompassing all types of biomaterials 
was recently given by Williams (2008): “the ability of a biomaterial to perform its desired 
function with respect to a medical therapy, without eliciting any undesirable local or systemic effects in 
the recipient or beneficiary of that therapy, but generating the most appropriate beneficial cellular or 
tissue response in that specific situation, and optimizing the clinically relevant performance of that 
therapy” [9]. 
The prefix bio- can be defined as ‘life or living things’, but often it can also refer to 
something that benefits life, as in the case of the term ‘bioceramics’ [91]. The 
challenges with using the prefix bio- was recently (2009) brought up by Williams [91] in 
his leading opinion journal article in Biomaterials. He reminds us of the need to accept 
that different disciplines can use the same words for totally different meanings (c.f. 
automotive company with a biomaterials department). In the same article, the essence 
of biomaterials is discussed from several viewpoints. Furthermore, the classical 
definition of biomaterials formulated ten years earlier is challenged, and as a 
conclusion, William suggests a new definition for biomaterials which takes into 
account the novel 21st-century biomaterials. 
The definition of biomaterial has undergone many revisions and debates, as 
indicated by the development steps summarized in Table 1. The definitions given in 
Oxford English Dictionary (1999) [92] and in Larousse dictionary of science and 
technology (2006) [93] are not in line with the other definitions. These give too 
simplified a picture of biomaterials and can cause misunderstandings. Otherwise, the 
definitions reflect shifts in thinking and material development over the years. In the 
table, examples of emerging biomaterials of each ‘era’ are given which do not fit the 
previous definitions and which gave rise to modifications of the definitions. The 
examples are intentionally limited to materials used to replace, repair, or regenerate 
parts of the musculoskeletal system of the body. Reviews concerning bone-matrix 
synthesis and skeletal-function relationships are given in [94-97]. 
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Table 1. Evolution of the definition “biomaterial” and examples of emerging implant materials  
Year Definition Implant materials emerging 
1860s* Possible to implant materials without infections – first 
time advantageous to use surgical procedures [89] 
Fe, Au, Ag, Pt, Ni, steel [89] 
   
1945** Causing no or only minimal reactions when inserted in 
body - lack of toxicity, concerns about biodegradation 
products from metals, alloys, and polymers [98] 
Ceramics [14, 98, 99], PMMA, Ti 
and its alloys [89] 
   
1974 “A biomaterial is a systemically, pharmacologically inert 
substance designed for implantation within or 
incorporation with a living system.” ([100] in [89]) 
Bioactive ceramics [101, 102] 
   
1982 “A biomaterial is any substance, other than drug, or 
combination of substances, synthetic or natural in origin, 
which can be used for any period of time, as a whole or 
as a part of a system which treat, augments or replaces 
any tissue, organ or function of the body.” [103] 
Composites [104] 
   
1986 “A non viable material used in a medical device, intended 
to interact with biological systems.” ([90] in [103]) 
 
   
1991 “A material intended to interface with biological systems 
to evaluate, treat, augment, or replace any tissue, organ, 
or function of the body.” [103] 
Tissue-engineering scaffolds [73]  
   
1999 “An organic substance of biological origin, esp. one 
forming part of the structure of an organism. Also: a 
material (typically wholly or partly synthetic) used for 
prostheses, medical implants, etc.; such materials 
collectively.” [92] 
 
   
2006 “A solid material which occurs in and is made by living 
organisms, such as chitin, fibrin or bone” ([93] in [91]) 
 
   
2009 “A biomaterial is a substance that has been engineered to 
take a form which, alone or as part of a complex system, 
is used to direct, by control of interactions with 
components of living systems, the course of any 
therapeutic or diagnostic procedure, in human or 
veterinary medicine.” [91] 
“Nanoscale” materials [99, 105, 
106], (Non-)viral vectors (such as 
polymers with embedded DNA, 
able to introduce DNA into 
target cells) [91, 107-109] 
*time after the aseptic surgical technique developed ** time after Second World War 
 
Prior to the first aseptic surgical procedures developed by Dr. Lister in the 1860s 
[89], the usage of biomaterials was trial-and-error-based reconstruction of missing or 
defective parts of the body [88]. Until the 1970s, the golden rule was that implantable 
materials should be as inert as possible and only replace a missing function in the body. 
These nearly inert materials, including metals, ceramics, and polymers, formed the so 
called first-generation biomaterials [11, 96, 99]. These materials are still widely used 
today in various applications. 
The second-generation materials are aimed to repair tissue. These materials, 
radically different from their predecessor, the 1st-generation materials, interact with the 
body and generate reaction products which are beneficial to the host tissue [8, 14, 99]. 
Materials that are able to have a biological effect or be biologically active, and form a 
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bond between the tissues and the material, are called bioactive materials [110]. Because 
of the 40th anniversary (1969-2009) of the invention of the concept of bioactive 
materials, many review articles concerning the past, present, and future of especially 
bioactive ceramics have been published recently [8, 14-16, 24, 64-66, 96, 99, 111]. 
Bioactive materials are considered to have the ability to directly attach to bone without 
a fibrous capsule, and the bonding strength is typically equivalent or higher than the 
strength of the implant material or the tissue bonded to the implant [26]. Thus, if a 
mechanical fracture occurs, it usually starts either in the implant or in the bone but not 
at the interface.  
The first true consensus over the term biomaterial was gained as late as 1986 at the 
Consensus conference hosted by the European Society for biomaterials [103]. The 
definition included the term ‘interact’, taking into account 2nd-generation materials. In 
the next definition, the term ‘interact’ is changed to ‘interfere’, which takes into 
account materials designed to regenerate tissue instead of only repairing, thus leading 
into 3rd-generation materials. This generation of materials emphasizes the meaning of 
bio in the term biomaterials [112, 113]. The latest definition (2009) introduces the 
engineering aspect to the definition and widens even further the range of possible 
materials. Materials now being considered include viral vectors, used as DNA carriers 
to specific cells [91, 107-109], and hybrid sol-gel materials where inorganic and organic 
materials meet with domain sizes approaching the molecular level enabling engineering 
of the material nanostructure [114-116]. 
It may well be that traditional 1st- and 2nd-generation biomaterials will lose some of 
their previous interest in the research field, but it is undoubtedly clear that they will 
still, for a long time, serve in clinical applications as such and as substrates and 
templates for 3rd-generation biomaterials [10, 99]. To gain the best answers for the 
growing demand of functional biomaterials, highly multidisciplinary approaches are 
required, which further increases the need for a clear vocabulary. Consequently, the 
continuous updating of the definitions is vital. 
The next chapters concentrate on the principal biomaterial studied in this work, i.e. 
glass, and the discussion is limited to melt-derived silica-based oxide glasses and glass-
ceramics derived from these glasses. 
2.2. Biocompatible glasses and glass-ceramics 
As is now clear by definition, biocompatible glasses and glass-ceramics are materials 
desired to generate the most appropriate beneficial cellular or tissue response in a 
specific situation. However, the definition does not explain what type of glass 
dissolution behavior is desired in various applications. The non-stable human body 
environment puts several demands on the implant materials used to replace or 
augment tissue functions. The degree of glass reactivity desired varies according to 
implantation situation; the only common factor is the non-toxicity. 
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In bioresorbable glass applications, such as bone fracture pins and screws, the glass 
in the composite structure should give mechanical support during the bone fracture 
healing period and then degrade [67, 79]. The dissolution rate should match the growth 
rate of the new tissue [73, 81], which in some cases may be slow. In certain 
applications, such as dentures reinforced with continuous E-glass fibers, glass should 
be inert and maintain its mechanical properties under several loading cycles and for a 
long time [117-119]. 
Today, though, glass is most often designed to act as bioactive bone-grafting 
material in medical implantations and operations. Glass supports bone formation via 
dissolution and formation of a hydroxyapatite (HA) surface layer. However, after the 
discovery that the ion release products from bioactive glasses activate several families 
of genes [120-123], among others genes that regulate osteogenesis and the production 
of growth factors, glass research has more and more shifted towards tissue 
regeneration where glass is desired only to dissolve and offer soluble elements and ions 
to the genes. The role of the various dissolved ions and ion release kinetics from the 
glasses on the human cell behavior has recently been reviewed by Hoppe et al. [39]. 
The reactivity of glass and glass-ceramics in the body environment is highly 
compositional dependent, but several other factors should also be considered (see 
2.2.4). Below, the general structural features of glasses and the reaction mechanisms of 
glasses in aqueous solutions are reviewed. 
2.2.1. Glass and glass-ceramics – structural features 
Glass has several characteristics which make it a superior material for medical 
applications, ranging from fiber optics for endoscopy, thermometers, insoluble porous 
carriers for antibodies and enzymes to bioactive implants, fillers in bioabsorbable 
composite structures, and tissue-engineering scaffolds [26, 29, 77, 124, 125]. Glass has 
a certain compositional freedom allowing a wide variety of characteristics, such as 
formability, chemical durability, strength, and optical properties. Several of these 
properties can be smoothly adjusted by the composition within a certain range [126], 
and this has been exploited in various phenomenological models and optimization 
routines [34, 46, 127-135]. Glass properties, however, depend not only on the 
composition but also on the thermal history of the sample, such as cooling rate, 
annealing time, and hot-working of the glass. The relevant structural and kinetic 
theories of glass formation have been reviewed in the PhD thesis by Arstila [44], and 
the viscosity-temperature relationships in the PhD thesis by Vedel [56]. 
In general, glass can be described as a solid with a liquid-like atomic structure, i.e. 
atomically disordered solid. Glass, especially melt-derived oxide glass, is often defined 
by using the following definitions: 
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 “an amorphous solid completely lacking in long range, periodic atomic structure, and exhibiting a 
region of glass transformation behavior” 
[5] 
 
 “an inorganic product of fusion that has cooled to a rigid condition without crystallization” 
(ASTM ) 
[136] 
 
The amorphous SiO4 tetrahedral network forms the backbone structure for silica-
based glasses. These SiO4 tetrahedra are connected at the corners in various 
orientations to form a continuous 3D network. Each oxygen atom can act as a bridge 
between neighboring tetrahedra. The local configuration around each silicon atom is 
expressed with Qn notation, where n is the number of bridging oxygen (BO) ranging 
from 0 to 4. The role of alkali and alkaline earth oxides is to modify the network 
structure, i.e. these oxides reduce the degree of connectivity in the network by 
replacing BO by non-bridging oxygen (NBO), thus opening up the glass structure. The 
strength of the individual modifying ion–oxygen bond together with the number of 
NBOs determines several glass properties, such as viscosity and chemical durability. 
The role of various glass components and their effect on different physical and 
chemical properties has been discussed by Paul [137], Shelby [5], and Varshneya [136], 
among others. The usage of accurate structural analysis techniques, such as MAS-
NMR, combined with powerful computational tools has substantially increased the 
knowledge about the detailed structure of glasses [19], and detailed structural features 
of silica-based glasses have been widely reported [19, 37, 136, 138-153]. There are also 
several other glass forming systems than silicate. Especially, phosphate- and borate-
based glasses have lately gained increased attention in bioactive glass research [40]. The 
structural features of phosphate glasses have been discussed by Brow [154] and 
Kirkpatrick and Brow [155], and the structural features of borate and alkali borosilicate 
glasses by Hannon et al. [156], Krogh-Moe [157], and Vedishcheva et al. [158]. 
The strength of glass is defined as the applied stress on failure [136]. Mechanical 
properties are highly dependent on the surface condition of the glass, i.e. presence of 
microscopic flaws and cracks, which will propagate under tensile loads. The loading 
leads to uncontrolled crack growth until the glass physically breaks [136]. The 
phenomenon is commonly known as fatigue. The theoretical strength of flawless solid 
silicate glass is ~35 GPa [136, 159], while for instance some steel alloys can reach 
strengths higher than 1000 GPa. Strength of oxide glasses and the different 
experimental techniques to measure it have been recently reviewed by Kurkjian [159]. 
However, the ability of a glass to resist fracture when a crack is present, i.e. fracture 
toughness, is low. Thus, already small flaws decrease the strength noticeably, and 
typical strength of common glass products is only around 14-70 MPa [136]. Thus, 
glasses are brittle and they fail without yielding as indicated by the high Young’s 
modulus of silicate glasses, 45-100 GPa [160]. The corresponding values of cancellous 
(“spongy”) bone and cortical (“compact”) bone are .05-0.5 MPa and 7-30 MPa, 
respectively [13]. The compressive strength of bioactive silica glasses is around 800-
1200 MPa [6] and tensile bending strength is 40 to 60 MPa, depending on the 
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composition of the glass [13]. As a comparison, the compressive strength of cancellous 
bone is 2-12 MPa and that of cortical bone 100-230 MPa [13]. 
It has been demonstrated that amorphous porous bioactive glass structures can be 
sintered from bioactive glasses having a wide hot-working range [35, 161-163]. In 
general, the compression strength of porous glassy implants is of the same order as 
that of cancellous bone. A higher sintering temperature usually increases the strength, 
but it also increases the amount of crystallization and reduces the porosity. If 
crystallization occurs too rapidly, it interferes with viscous flow sintering. Partial 
crystallization of the glass particles decreases the viscous flow sintering [164] and 
produces a residual glassy phase whose viscosity deviates from that of the parent glass. 
Crystallization of bioactive glasses has been discussed in detail in the PhD thesis of 
Arstila [44]. 
The mechanical strength and toughness of glass can in some cases be significantly 
improved by controlled crystallization. For example lithium disilicate glass-ceramics 
have been shown to have bending strengths of around 700 MPa while still being 
translucent [165]. Special shades and various degrees of durability, ranging from highly 
durable to resorbable, can also be tailored by changing the glass composition [166]. 
One further advantage with apatite- and mica-based glass-ceramics is that they can be 
easily processed by drilling [101, 166, 167]. Glass-ceramics, originating from the mid-
1950s, are materials that are composed of one or more glassy and crystalline phases 
formed through controlled nucleation and crystallization of glass [168]. The principles 
of producing glass-ceramics are well described by Höland [166] and Hill [101]. The 
applications and developments in the area have been reviewed by Höland [166, 169], 
Höland et al. [170], Pannhorst [171], and Zanotto [168]. Recently, considerable effort 
has been directed towards the development of different types of glass-ceramics for 
tissue-engineering scaffolds and dentistry (e.g. [24, 76, 170, 172, 173]). 
The glass-composition and various nucleation agents affect the crystallization 
mechanism (bulk or surface) [166]. In addition to the glass composition, the glass-
ceramic designer can alter the microstructure by controlling the heat-treatment 
parameters. Glass-ceramics can also be produced by sintering glass powder or 
granulate (sintering mechanisms are reviewed by Prado [164]). The porosity of the 
material can be controlled by varying the nominal grain size and heat-treatment 
parameters. All these parameters give high flexibility for the tailoring of the material 
properties. However, because glass-ceramics consist of multiple phases and structures, 
the control of the processing is difficult and the dissolution properties cannot be as 
easily mathematically modeled as for glasses. Furthermore, the residual internal stresses 
and mismatches of the different phases may influence the strength and durability of 
the glass-ceramics [174]. 
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2.2.2. Glass durability 
It is vital that the ion release from any glasses used in medical application is controlled. 
According to Morey [4], producing a glass stable enough to serve its intended purpose 
places a practical limit on the compositions which may be employed. With knowledge 
of the reactions and reaction mechanisms taking place in contact with aqueous 
solutions in vitro, the compositions of the glass can be tailored for various implantation 
conditions.  
Glass is in general considered highly durable. In several applications, the chemical 
durability is well above the product need, and thus it seems to be of less importance 
[175]. However, all glasses will react under certain conditions with aqueous solutions, 
only the time scale varies. Glass durability is usually referred to as the resistance to 
proton-alkali ion exchange between an aqueous solution and a glass surface. Chemical 
durability or stability is defined as the resistance which glass offers against the chemical 
attack by water, humidity, and of aqueous solutions of acids, bases and salts. The term 
hydrolytic resistance describes specifically how well glass withstands reactions with 
pure water, and can be classed as a subgroup to chemical durability. The term 
weathering describes the durability against elements in atmosphere, especially, 
humidity. Durability is measured through several approaches related to the final use of 
the glasses. However, no absolute measure of chemical durability exists, which is why 
durability is often determined in a relative scale in which different glasses are compared 
at similar experimental conditions [137]. Typical durability tests are reviewed in 2.3. 
Predictions of glass dissolution in aqueous solutions can be made by a combination 
of theoretical models and experiments. Traditional modeling techniques used for 
predicting glass dissolution are based on analytical (kinetics), geochemical (transition 
state), and thermodynamic (free hydration energy) models [135, 175-182]. Thanks to 
increased computational power, more sophisticated approaches have become available. 
Hard and soft computational techniques available for modeling glass dissolution are 
well described by Aertsens and Ghaleb [135]. Because glass dissolution modeling is 
outside the scope of this work, this theme is not elaborated further, but it is recognized 
that the results presented here could be used as a source data for predictive models. 
2.2.3. Glass in contact with aqueous solutions 
Whereas the corrosion mechanisms of metals or ceramics may be described by fairly 
simple chemical dissolution, much more complex reactions occur for glasses. 
According to the definition, corrosion is “the degradation of a metal by an electrochemical 
reaction with its environment” [183]. Despite the contradiction to the original definition, the 
term corrosion has become well recognized in the literature on glass. It is used more or 
less as a synonym to dissolution or network breakage of glass. As glasses for medical 
applications are, however, usually designed to react with the body environment, the 
negative tone of the term ‘glass corrosion’ is unsuitable [53]. Hence, in this work, the 
term ‘glass reactions’ is used instead. 
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The glass dissolution reaction mechanisms are well described in the literature [26, 
181, 184-195]. Glass can either dissolve congruently, i.e. uniformly, which implies that 
the ratios of elements in the solution are the same as in the dissolving glass, or 
incongruently, i.e. to show preferential dissolution/leaching [190]. The reaction 
mechanisms depend on both glass composition and the environmental conditions such 
as surface area to volume ratio and pH of the solution. Relevant parameters affecting 
reaction mechanisms and kinetics of glasses in body environment are reviewed in 2.2.4. 
The glass reactions in contact with aqueous solutions are often divided into primary 
and secondary reactions: (1) ion-exchange, hydration, and hydrolysis, and (2) 
precipitation. The primary reaction steps for a simple sodium silicate glass are 
summarized in Figure 5. Each of the reaction steps will be described separately in the 
following paragraphs, even though in reality the reactions are strongly coupled to each 
other [185, 191, 195]. The reaction steps reviewed here are restricted to reactions 
typically taking place at the surface of silicate glasses. 
During the first tens of milliseconds when a glass is in contact with aqueous 
solutions, an electrochemical equilibrium is established at the glass surface ([196-198] 
in [187]). At pH < 9, a selective leaching process dominates [199, 200] and an ion 
exchange reaction, i.e. interdiffusion of protons from the surrounding solution and 
alkali and earth-alkali ions from glass, follows the electrochemical equilibrium (step 2 
in Figure 5). 
 
Figure 5. Phenomena observed during the formation of the subsurface zone of a simple sodium 
silicate glass: (1) instantaneously established electrochemical surface equilibrium; (2) ion 
exchange; (3) cleavage of silica bonds (network dissolution); (4) condensation of initially formed 
silanol groups (gel formation reaction); (5) fast exchange of metal ions, protons, and molecular 
water across the subsurface zone. [187] Reproduced with permission of John Wiley and Sons. 
In the ion-exchange reaction, mobile ions are leached out from the glass matrix 
leaving the matrix material more or less intact, and the charge balance is maintained 
[190]. The field strength and the radius of the network-modifying ion affect the 
mobility, i.e. as the charge-to-radius ratio of the cation decreases, the mobility 
increases. Thus, the alkali ions are the most mobile, and furthermore ions with a larger 
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ionic radius are more weakly bound to the NBOs and consequently more mobile than 
ions with a smaller radius. Dissolution of K2O-containing glasses have been shown to 
be many orders of magnitude faster than Li2O-containing glasses [189]. Additionally, 
water may enter the glass structure as molecular water (hydration). 
Example of ion-exchange (1) and hydration (2) reactions are given below [191]:  
 –Si–O-M+ (glass)+ H+ (aq) → –Si–OH (glass) + M+ (aq) (1) 
   
 –Si–O-M+ (glass)+ H2O (aq) → –Si–OH (glass) + M+ (aq) + OH- (aq) (2) 
 
A comprehensive list of water reactions with the glass network is given by 
Grambow et al. [201]. According to Bunker, alkali leaching is not a reversible reaction 
because the formed silanol groups react with each other to form Si-O-Si bonds [191], 
whereas Grambow et al. consider the backward reaction possible [201]. The rate of 
molecular water diffusion is mainly determined by the structure of the glass, i.e. the 
size of voids between oxygens [191]. If the voids are too small, the only way for water 
is to enter the structure via hydrolysis, which is the case for most glasses [191]. 
Leaching continues inwards to the bulk, and the proton on the silanol group (Si-OH) 
can change sites with an inner M+ [136]. Consequently, the phase notation for M+ 
could also be ‘glass’ in reactions 1 and 2 because the M+ may be trapped in the glass 
structure [201]. To maintain the charge balance in the glass structure, some internal 
condensation of molecular water needs to take place. This might explain the observed 
percolating water phase in the structure [187]. In addition, for soda-lime glasses it has 
been shown by isotope labeling of water that the ion exchange of Na+ occurs purely 
with neither with H+ nor H3O+ [187]. An example of a leached layer is shown in 
Figure 6. From the cross-sectional SEM image of bioactive glass S53P4 after 1 week of 
immersion in 10-% lactic acid (pHt=1 week = 2.9), a typical sharp interface between the 
leached layer (dark gray) and the bulk glass (light gray) can be observed.  
  
Figure 6. The cross section of bioactive glass S53P4 after 1-week immersion in 10 % lactic acid 
showing a leached silica rich layer, picture provided with courtesy of Leena Varila, ÅA [202] 
200 µm
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The ion-exchange reaction is often described with Fick’s law, here given for one 
dimension (3): 
 
  
  
  
 
 
  
  
  
  (3), 
 
where D is the diffusivity of the dissolving ions. For a planar interface with 
constant surface conditions, the solution of the equation leads to a parabolic rate law 
[190], and thus the amount of alkali dissolved should be proportional to the square 
root of time. If sufficient amount of liquid is available, the reaction ends only when the 
entire glass sample has undergone an ion-exchange reaction [190]. However, as the ion 
exchange is not the only reaction, the extent and the relative rates of other 
simultaneous reactions control the glass dissolution process and the kinetics of alkali 
leaching [195].  
The excess hydroxyl (OH) ions in the solution resulting from the cation exchange 
in the glass with H+ in the solution act as a catalyst for network dissolution [152]. At 
the alkaline region (pH >9), the hydrolysis reaction (reaction 4 and reaction step 3 in 
Figure 5) starts to dominate, causing depolymerisation of the glass structure. A silicon 
bridge is opened in the hydrolysis reaction. The reaction is caused by the nucleophilic 
attack by OH- and leads to a more open glass structure. As shown in Figure 5, 
the -Si-OH groups may react further, which gradually leads to the dissolution of the 
glass network (soluble silica). The simultaneous condensation reaction (reaction 5 and 
reaction step 4 in Figure 5), where the formed silanol groups are polymerized again to 
Si-O-Si bonds, may take place. This leads to enrichment of surface SiO2 and to 
formation of a gel-like layer.  
 –Si–O–Si (glass)+ OH- (aq) ⇌ –Si–OH (glass) + Si–O- (glass) (4) 
   
 –Si–OH (glass)+OH–Si– (glass) ⇌ –Si–O–Si (glass) + H2O (aq) (5) 
 
Molecular water is released by the condensation reaction, and it can react further, 
increasing the rate of network dissolution. The condensation reaction may lead to a 
structure with enhanced connectivity ([203] in [187]), increasing the diffusion of water, 
but simultaneously many of the ion exchange sites are eliminated in the process [191]. 
Also, a structural compaction of the outermost layer and closure of the formed pores 
has been reported ([184, 186], [204] in [187]), which would further retard dissolution. 
When the solubility limit of the dissolved ions is exceeded, a secondary reaction, i.e. 
precipitation, occurs. The precipitation may take place on suitable nucleation sites 
either on the glass surface or inside the leached layer. The precipitated layer may act as 
a diffusion barrier and protect the glass from further dissolution [188]. The precipitate 
layer also acts as a substrate for further adsorption [190], and several secondary layers 
may form. Given enough time an initially amorphous precipitated layer can crystallize. 
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An example of a secondary reaction layer, calcium phosphate (CaP), formed on top 
of a leached layer is given in Figure 7 (unpublished image from data set published in 
[205]). Bioglass® 45S5 was immersed in simulated body fluid (SBF) for one week. SBF 
resembles the inorganic part of human extracellular fluid [206]. 
The CaP layer is formed by migration of Ca2+ and PO43- groups to the surface 
through the SiO2-rich layer by incorporation of soluble calcium ions and phosphates 
from the solution [26, 207] or simply by precipitating from appropriate solutions. With 
time, the CaP layer crystallizes into HA. Also other anions, such as F-, OH-, and CO32-, 
may be incorporated into the crystalline structure [26, 207]. This crystallized HA is 
similar to that in natural bone. The biological HA acts as reinforcement in hard tissue 
being responsible for the stiffness of bone, dentin, and enamel [89]. The formed HA 
layer is able to form a chemical bond with natural bone via a series of biological 
reactions. The formation of an HA layer on the leached silica-rich layer may act as a 
diffusion barrier, depending on the density of the layer. This decreases the driving 
force for further dissolution and might partially help explain why, with some bioactive 
glass compositions, intact core glass is still found after several years of implantation as 
reported by Lindfors et al. [28].  
To summarize, the reaction sequences leading to bone bonding in the body 
environment follow the same reaction steps as presented above [26, 207]. These 
reactions may partly occur also for conventional soda-lime glasses (SLG). However, 
rates for the primary reactions are slow for SLG, and thus they are encapsulated in the 
body [26]. These primary stages are followed by the formation of a CaP layer on 
bioactive glasses. The additional steps include adsorption of biological moieties, such 
as proteins, to the reaction layers, followed by the action of macrophages and stem cell 
attachment, among others [26, 113]. The reaction sequence leading to bone bonding 
can up to HA formation be simulated in vitro with various aqueous inorganic solutions, 
and they occur during the first hours for Bioglass® 45S5 [26].  
 
Figure 7. The precipitated CaP layer on top of the leached silica-rich layer on 45S5 after one-week 
immersion in SBF (unpublished image from data set published in [205]) 
10 µm
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(Silica rich layer)
Bulk glass
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2.2.4. Reactivity - bioactive to bioinert and vice versa 
The reactivity of glass and glass-ceramics in a body environment is highly composition 
dependent, but several other factors affect as well. Sample form, surface morphology, 
dosage, and implantation site all play an important role. Figure 8 shows parameters 
which affect glass durability, and thereby also the reactivity. Naturally, when the glass is 
implanted in the human body the solvent and the environmental parameters, apart 
from the surface area to volume ratio (SA/V), cannot be affected. Thus, the variables 
that can be affected, i.e. glass composition and sample parameters, should be 
determined by the glass engineer prior to clinical implementation.  
 
Figure 8. Various parameters affecting glass durability 
As mentioned in the introduction, the first bioactive glasses were based on the 
Na2O-CaO-P2O5-SiO2 oxide-system [29]. The first composition, 45S5, that was shown 
to form a bond with bone consisted of (wt %) 24.5 Na2O, 24.5 CaO, 6.0 P2O5. 45.0 
SiO2. 45S5 is still today the most bioactive glass composition available, and most of the 
research is concentrated around this composition. In the Na2O-CaO-SiO2 ternary 
phase diagram, the compositional dependency of bone bonding and reactivity 
according to Hench is shown (Figure 9) [8]. Class A bioactivity (region S in the figure) 
implies that the glasses bond both to bone and to soft tissue, while class B (green 
region) bonds only to bone [29]. The glasses in blue area are not bioactive and react 
only slowly. The composition of these glasses is close to traditional soda-lime glasses 
(SLG). However, it needs to be kept in mind that SLG are multi component glasses 
containing also several other oxides. The blue region might be of interest when glass is 
wanted to give only temporary support to bone healing, while the yellow region might 
be suitable to drug delivery applications. 
The atomic structure of glass is directly related to composition, and therefore to the 
dissolution rate. Already seemingly small changes in glass composition affect 
bioactivity. For example, an addition of 1-1.5 wt% Al2O3 has been shown to 
significantly reduce bioactivity [34]. Often the connectivity of the silica network is 
related to bioactivity [208-213]. It was recently reported by Hill and Brauer [212] that 
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the phosphate content and the network polymerization (Qn structure) strongly 
influence glass dissolution and subsequent apatite formation. The authors showed that 
different network models may be useful in predicting bioactivity in simple SiO2–P2O5–
CaO–Na2O glasses. However, when more components are added to the glass systems, 
care should be taken when using network based models. 
Typically, the compositional effect studies have been limited to the substitution of 
one or two components in a certain glass composition [57]. However, in vitro and in vivo 
behavior have also been reported [34, 46, 48, 130, 214] for multi-component systems 
with five to seven oxides in order to study the compositional dependency of the 
dissolution rate. The compositional effects on the reactivity of bioactive glasses have 
been reviewed recently by Hupa [126]. In addition, reviews on the effect of various 
elements to the bioactivity are also given in PhD theses by Zhang (2008) [57], Ylänen 
(2000) [41], and Brink (1997) [55]. Recently, the effect of the addition of elements like 
Ag, Cu, F, K, Mg, Sr, and Zn to the bioactivity of the glasses have been reported [31, 
32, 35-38, 144, 146, 147, 215-218]. Despite extensive research efforts, the effect of 
composition on the properties of bioactive and biodegradable glasses is far from fully 
understood [126]. 
 
Figure 9. Compositional diagram for bone-bonding. Region S is a region where bioactive glasses 
bond to both bone and soft tissues and are gene activating. [8] Redrawn according to L. Hench 
(2006) [8]. 
It has been shown that glass composition alone does not determine bioactivity. 
Glass which in one physical form is bioactive may fail to show bioactivity in another 
form [219]. In a study of Alm et al. [219], the bioactive glass composition 1-98 failed to 
demonstrate a positive effect on osteogenesis in the form of thin fibers in a composite 
structure. Earlier, though, a positive effect was observed with the same glass in the 
form of solid discs and sintered microspheres [47, 220]. The large surface area given by 
the thin fibers together with the fluid flow around the fibers caused rapid resorption of 
the glass. Particle size has also been shown to play a role in the in vivo and clinical 
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behavior of bioactive glass [221-227]. In general, better bone formation has been 
observed with large granules and/or with a broad particle size range (typical size > 500 
µm or size range 90-710 µm) than with smaller particles (typical ~20 or 100-300 µm). 
No clear difference in the bone formation has been reported for the large granules of 
different sizes. 
The effect of glass dosage on dissolution behavior and cell cytoxicity has been 
reported [228, 229]. The results indicate that the rate of HA formation on bioactive 
glass powders in vitro depends on the concentration of the powders in solution [229]. 
In a study where submicron bioactive glass particles were used, the cell activity 
decreased with increasing dosage [228].  
2.3. Glass dissolution measurements 
When glasses are placed in aqueous solutions, changes occur both in the glass and in 
the solution [193]. Thus, a wide variety of analysis methods and experimental setups 
are needed to characterize the dissolution process. Typical analysis methods utilized to 
characterize glass dissolution are listed in Table 2 together with example references to 
bioactive glass studies where these analysis methods have been used.  
Table 2. Typical analysis methods used to characterize glass dissolution 
 Analysis Method Utilized in 
Surface Fourier transform infrared spectroscopy (FTIR) [35, 230, 231] 
 (Solid state) Nuclear magnetic resonance spectroscopy (NMR) [144, 147, 153, 232] 
 Raman spectroscopy [218, 232] 
 
Scanning electron microscopy with Energy-dispersive X-ray 
spectroscopy (SEM-EDX) 
[43, 130, 233, 234] 
 Surface area measurements [231] 
 X-Ray Diffraction (XRD) [231] 
 X-ray microtomography (μCT) [75] 
Solution Inductively coupled plasma optical emission spectroscopy (ICP-OES)* [84, 235] 
 pH measurements [84, 130, 144] 
 Spectrophotometry (SPM)** [130] 
 Titration [236, 237] 
* Synonym:  Inductively coupled plasma atomic emission spectroscopy (ICP-AES), **Nowadays usually replaced by ICP 
based measurements 
 
Unlike in a body environment, several parameters are available to be adjusted when 
an in vitro dissolution experiment is designed. The characteristics of the solvent, both 
initial pH and ionic composition, are the most decisive factors for the outcome of the 
experiment [238]. The pH effect on glass dissolution has been already well established 
[192, 200], but solution movement is less recognized. It affects the environment 
around the glass sample, and consequently also the reaction mechanisms and rates. 
Dissolution studies are often conducted under static conditions, which may lead to 
increased pH values and local saturation [239]. In this thesis, these are defined as 
conventional dissolution measurements. Studies where only mixing or agitation of the 
solution is used are also placed in the same category. Measurements where some kind 
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of movement of the solution occurs are called dynamic in the literature. Thus, in this 
thesis the term ‘continuous’ was chosen instead of ‘dynamic’ to describe all studies 
where the solution is continuously flowing with respect to the sample. When flow tests 
are used, the solution composition and the pH can be more easily controlled than in 
static tests [238]. 
Many of the traditional glass dissolution studies are performed under accelerated 
conditions. Such conditions can be obtained by using elevated temperatures and high 
glass surface area to solution volume ratios (SA/V) [238]. These types of accelerated 
experiments are crucial when glasses used for long-term storage of nuclear waste are 
studied [201, 240]. Not unexpectedly, the increase of temperature has been shown to 
have a significant effect on the glass dissolution rate (as a rule of thumb, glass 
dissolution rate is roughly doubled per every 8 to 15°C increase [137]), and it is found 
to follow the Arrhenian type of behavior [137, 192, 241, 242]. A high SA/V can be 
obtained for example by using powdered glass or thin fibers. However, the 
specification of the surface area of the particles may be difficult because of the 
crushing and sieving procedure needed to make the particles. There are always fine 
particles attached to the surface of the larger particles, and the particle shape and size 
fraction may vary considerably. 
2.3.1. Conventional glass dissolution studies 
Because the chemical resistance or durability of glass is not as easily defined as 
properties such as viscosity or thermal expansion, several standardized test methods 
have been developed. The need for standardized testing originates mainly from the 
container and float glass industry where it is necessary to evaluate how the product will 
withstand the intended consumption and wearing [190]. However, nowadays also the 
bioactive glass research community moves towards standardized test procedures to be 
able to compare the reactivity of various glass compositions. 
One of the commonly used methods to test the durability is the ISO 719 standard, 
which measures the hydrolytic resistance of glass grains at 98°C [243]. The ISO 719 
test is cheap, easy, and fast for industrial quality control. The scale of hydrolytic 
resistance ranging from one (durable) to five (non durable) is often used to compare 
soda-lime glasses. Other similar standards include leaching in water at 121°C (ISO 
720), acid resistance test (DIN 12116), and alkali resistance test (ISO 695). These are, 
however, not of great interest in designing glasses for biological applications because 
they are designed mainly for highly durable glasses (e.g. borosilicate glasses for 
laboratory ware use). The ISO 719 test has also been utilized for studying the reactivity 
of bioactive glasses [55, 244]. However, no real correlation between bioactivity and 
durability has been reported. Andersson et al. reported a phenomenological model for 
chemical durability of bioactive glasses, suggesting that the first hour of corrosion may 
correlate with the biological behavior [244]. However, no real conclusions were made 
based on the hydrolytic resistance experiments. Most of the glasses studied by Brink 
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[55] exceeded the upper limit of the standard, and the pH of water after the test rose to 
values above 9. This implied that network dissolution was also occurring and the 
dissolved silica affected the result. Therefore, she suggested that the standard should 
be modified so as to be applicable to bioactive glasses as well. The durability results 
obtained by Brink [55] were, however, suggested to correlate with the in vitro 
chemiluminescence activity of human polymorphonuclear leukocytes [245]. Based on 
the findings of Andersson et al. [244] and Lindfors et al. [245], it seems that the 
ISO 719 test gives a good preliminary estimate of the reactivity of the glass. Thus, this 
method was also included in this thesis. In addition to the standard measurements, also 
the dissolved ions were measured in this work. 
In vitro reactions of bioactive glasses are commonly studied in buffered inorganic 
solutions under static conditions to evaluate whether CaP precipitates on the sample. 
CaP precipitation has been used as an indication of in vivo bioactivity [246]. Some 
studies have been performed under mixing or agitating conditions [229, 247]. The 
studies are usually performed in TRIS [248] or SBF [206]. The bioactive glass reactions 
in TRIS and SBF are well reported, and studies comparing bioactive glass reactions in 
these solutions are also available [218, 249]. In addition, purely phosphate buffered 
solutions (PBS) [250] and simple pure water [188, 249] have been used to study the 
glass reactions. However, PBS is normally used to evaluate hydrolysis of 
polymer/bioactive glass composites [251-254] and to produce HA from glasses for 
drug delivery applications [255]. According to the SciFinder Scholar library program, a 
total of more than 500 scientific papers dealing with SBF and glass have been 
published by June 2012. The corresponding numbers for TRIS and PBS are 70 and 40, 
respectively. 
There have been studies where the effect of TRIS-buffer on the dissolution 
behavior of glass has been evaluated [74, 256]. The presence of TRIS buffer has been 
reported to increase the glass dissolution. In thermodynamic calculations by Bastos et 
al. [257], the protonation and alkaline earth ion complexation with TRIS are reported. 
The authors state that the amount of free calcium and magnesium is reduced in a 
TRIS-containing solution because of the formation of complexed species. In TRIS, the 
amino group acts as a ligand for metal ions able to form complexed species. The 
formation of TRIS-complexed species could thus explain why the observed extent of 
dissolution was higher in TRIS than in water. 
It has been shown with thermodynamic calculations that SBF is a metastable 
solution and supersaturated towards apatite crystals [258]. Thus, if a material is 
immersed for a time longer than the induction time, i.e. the time for the metastable 
solution to become thermodynamically stable by precipitating apatite crystals, apatite 
precipitation will occur [259]. However, studies can be found where the authors are 
convinced about the bioactivity only by analyzing HA formation of the samples which 
have been immersed in SBF for several weeks (e.g [260]). Normally, though, multiple 
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analysis methods are used to evaluate dissolution behavior and the layer formation. 
There also exists a standardized method for detecting the apatite formed on a surface 
of a material in SBF (ISO 23317:2007), but this has been criticized, and a need for a 
new standard has been acknowledged [7]. 
2.3.2. Continuous glass dissolution measurements 
To better imitate the reality, different continuous testing methods have been 
developed. The continuous approach to glass dissolution has been mainly used in 
nuclear waste glass studies [261-263], but it has been also adopted in bioactive glass 
research [75, 264-267]. The characterizing parameter for these types of experiments is 
the ratio between transport and dissolution rates [190]. This ratio determines the 
dissolution type. Often, the same solution is circulated in the system causing changes to 
the original solution composition, and the sampling is performed at predetermined 
time intervals [75, 264, 266, 267]. In continuous measurements, the CaP precipitation 
process has been reported to be slower, and the flow rate has been reported to affect 
the layer formation [266]. 
By connecting a dynamic measurement method directly into a fast analysis method, 
such as pH or ion measurement, on-line data can be collected. This provides the 
possibility to estimate the reaction kinetics of glass dissolution. The idea of analyzing 
the outcoming solution and to gain a complete analysis of the extracted solution has 
been introduced already by Cross in 1959 ([268] in [194]). However, at the time, the 
trace element analysis techniques were not sensitive enough to allow successful 
analysis. Today, though, sensitive solution analysis techniques are available. 
Inductively coupled plasma optical emission spectroscopy (ICP-OES) offers a 
sensitive method, which has been in wide use for routine elemental analysis in the 
laboratories since the 1980s [269]. ICP-OES is based on atom emission spectroscopy, 
and the functional principles and instrumental details are well described by Dean [270]. 
ICP is an efficient atomization source with high tolerance for high salt concentrations 
[269]. The ICP-OES instrument consist of a high power radio frequency generator, a 
pneumatic nebulizer associated with a spray chamber, a torch, a dispersive system, a 
detector, and a computer [269, 270]. The advantage with atom emission spectrometry, 
dating back to the 1800s, is that photons can easily travel and be collected with simple 
optics [269]. Furthermore, the photons do not have a memory effect, and they do not 
degrade the detectors.  
ICP-OES enables qualitative and quantitative determination of metals and certain 
non-metals in solution. Furthermore, it is a multi-element technique with a wide 
analytical range. The detection limits offered by ICP-OES operated with simple sample 
matrices are in range of the parts per billion (ppb) in solution for many elements. Two 
main types of spectral interferences for ICP-OES can be categorized [270]: spectral 
overlap and matrix effects. The source of possible interferences needs to be carefully 
considered and evaluated when the experimental parameters and wavelengths for the 
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analysis are chosen. In addition, when modifications to the sample injection setup are 
made the sensitivity may decrease.  
ICP-OES can also be used for sensitive on-line analysis as discussed in this thesis. 
This approach has also been used in automatic dynamic chemical fractionation for 
advanced characterization of solid biofuels [271] and to do online dialysis to estimate 
bioavailability of minerals in nutrients [272]. The strength of the online approach for 
the solid biofuel analysis was that the overall extractable pools of ash-forming elements 
were quantified in merely 3 h versus 7 days in normal batchwise leaching tests. 
Similarly, the dialysis study the nutrients were digested and fully analyzed during the 
first 30 min. 
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3. Materials and methods 
The nominal oxide compositions of the glasses and the different experimental 
methods used in this thesis are collected in this chapter. The motivation for the 
choices of the glass compositions used in the dissolution part tasks was to study the 
chemical durability of glasses with various oxide compositions. In addition, already 
established compositions were chosen so that it would be possible to compare the 
obtained novel data to the available in vitro and in vivo literature [48, 128-131, 273, 274]. 
The glass compositions for the crystallization and sintering studies were chosen 
because of the general interest towards these glass compositions in the bioactive glass 
field. Furthermore, the experimental techniques for characterization of the changes in 
immersion solutions and glasses are summarized. The publications in which the 
experimental techniques are implemented are given in parenthesis after each section 
heading.  
3.1. Nominal oxide compositions of the glasses 
The nominal oxide compositions (weight %) of the glasses studied are summarized in 
Table 3 together with the corresponding publications. The glasses above the dashed 
line were prepared in-house, and the other glass compositions were of commercial 
quality. 
The nominal, i.e. theoretical, oxide composition of 45S5 was compared with the 
oxide composition of the actually melted glass by using data from energy dispersive X-
ray analysis (EDXA). In addition, a standard glass (from HVG-DGG), a commercial 
composition with strict quality requirements and specifications [275], was analyzed. 
Both glasses were analyzed as plates and particulates. Furthermore, 45S5 was also 
analyzed as cones (as used in [48]). The results from the comparison are given in 
Table 4. The relative standard deviation gives the difference between the analyzed 
points, and the Δ-value gives the difference between the nominal and measured oxide 
content. The results are intentionally given with extra digits to better emphasize the 
variations. 
Systematically higher Na2O and lower SiO2 contents were found for the analysis 
results. A larger deviation from the nominal composition for Na2O and SiO2 was 
observed when the sample was analyzed as particulates, as is clearly seen with the 
standard glass where the exactly same glass batch is analyzed in two sample forms. The 
deviation from the nominal composition is partly dependent on the fact that the oxide 
values are calculated, while a somewhat better agreement with the nominal values is 
obtained using the atom-% basis (Table 5). To gain a more accurate total 
compositional analysis, wet-chemical methods should be utilized. However, the results 
show that our melting procedure does not give any significant alkali losses due to 
volatilization because the Δ-values for standard glass and 45S5 are very similar. 
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Table 3. Nominal oxide compositions (wt%) of the glasses 
Glass code Na2O  K2O  MgO  CaO  B2O3  P2O5  SiO2  Reference 
45S5 24.5 
  
24.5 
 
6.0 45.0 I , III, IV 
S53P4 23.0 
  
20.0 
 
4.0 53.0 I , IV, VI 
1-98 6.0 11.0 5.0 22.0 1.0 2.0 53.0 I, II, IV, V 
13-93 6.0 12.0 5.0 20.0 
 
4.0 53.0 I, IV,V 
0106 5.9 12.0 5.3 22.6 0.2 4.0 50.0 IV 
0206 12.1 14.0 
 
19.8 1.6 2.5 50.0 IV 
0306 24.6 
  
21.6 1.3 2.5 50.0 IV 
0906 5.0 9.0 6.0 23.2 
 
0.8 56.0 IV 
1106 5.0 15.0 
 
20.6 
 
1.1 58.3 IV 
1306 22.1 
 
1.9 15.0 1.2 0.5 59.3 IV 
1406 5.5 11.2 3.4 16.3 2.0 0.7 60.9 IV 
1606 5.0 10.2 
 
15.0 2.0 4.0 63.8 IV 
1806 18.4 
 
0.1 15.0 1.5 
 
65.0 IV 
Tableware*, ** 14 7 
 
3 NA 
 
64 III 
E-glass* 0.1 0.7 0.7 23.5 6.4 
 
53.9 III, IV 
Standard glass (DGG-1)*  15.0 0.3 4.2 6.7 
  
71.7 III, IV 
Float* 15.2 
 
3.6 4.6 
  
72.6 III, IV 
* Contains also Al2O3: E-glass 14.1, Standard glass 1.2, Float 1.7, Tableware 1 
** According to EDX analysis, contains additionally BaO 8.2 and ZnO 3.3, NA not possible to analyze with EDX 
 
Table 4. Average oxide compositions for 45S5 and Standard glass analyzed in different sample 
forms using EDX 
Sample 
 
Na2O  K2O  MgO  CaO  P2O5  SiO2  Al2O3 
45S5 plate (N = 9) EDX (wt%) 25.65 0 0 25.05 5.90 43.27 0.11 
 RSD ( %)  3 - - 4 2 1 78 
 Δ (wt% points) -1.15 0 0 -0.55 -0.10 1.73 -0.11 
45S5 particles (N = 6) EDX (wt%) 26.09 0 0 25.36 5.77 42.10 0.19 
 RSD ( %)  14 - - 15 2 3 23 
 Δ (wt%) -1.59 0 0 0.86 0.23 2.91 -0.19 
45S5 cones (N = 16) EDX (wt%) 26.52 0 0 24.23 6.05 43.10 0.09 
 RSD ( %)  1 - - 1 2 1 107 
 Δ (wt% points) -2.02 0 0 0.27 -0.05 1.90 -0.09 
Standard glass plate EDX (wt%) 16.40 0.62 3.09 7.37 0 70.77 0.97 
(N = 3) Δ (wt% points) -1.40 -0.32 1.1 -0.67 0 0.93 0.23 
Standard glass particles EDX 18.12 0.32 3.53 6.53 0 70.47 1.02 
(N = 6) RSD ( %)  4 15 5 2 0 1 9 
 Δ (wt% points) -3.12 -0.04 0.67 0.17 0 1.24 0.18 
RSD calculated with all the samples, Δ (wt%) = Nominal – EDX 
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Table 5. Difference between nominal atom weight-% and analyzed atom weight-% for the same 
plate samples as in table above 
Sample 
 
Na  K  Mg  Ca  P  Si  Al 
45S5 plate (N = 9) Δ (wt% points) -0.86 0 0 -0.40 0.04 0.81 0.06 
Standard glass plate (N = 3) Δ (wt% points) -1.08 -0.08 0.66 -0.46 0 0.45 0.12 
Δ (wt%) = Nominal – EDX 
3.1.1. Sample preparation 
All the glass batches were prepared using the same protocol. The batches consisted of 
Belgian quartz sand (glass quality) together with analytical grade reagents listed in 
Table 6. They were melted in an uncovered platinum crucible for 3 h at 1360°C, cast, 
annealed, crushed, and remelted to ensure homogeneity. For glasses 1406, 1606, and 
1806 higher final melting temperature (≥ 1400°C) was needed to adjust the viscosity 
suitable for casting. 
Table 6. Chemicals, CAS numbers and producers 
Chemical CAS Producer 
Na2CO3 497-19-8 Sigma-Aldrich 
K2CO3 584-08-7 Sigma-Aldrich 
MgO 1309-48-4 Fluka 
CaCO3 471-34-1 Sigma-Aldrich 
H3BO3 10043-35-3 Merck 
CaHPO4∙2H2O 7789-77-7 Sigma-Aldrich 
SiO2 (Quartz sand)  origin Belgium 
 
In all publications, glass particles were used. Annealed glass blocks were crushed 
and sieved to give a desired size range fraction. No additional annealing of the glass 
particles was performed after crushing. To minimize fine-grained powder on their 
surfaces, the particles were rinsed with acetone in an ultrasound bath at least five times, 
or until the rinse solution was clear. After rinsing, acetone was evaporated, and the 
particles were dried at 120°C. An example of the glass particles (300-500 µm) before 
and after acetone rinsing is given in Figure 10. 
In publication I, the glass particles and glass fibers were studied. The 1–98 fibers 
were downdrawn semiautomatically from melt using laboratory scale fiber equipment 
with the same parameters as Arstila et al. [276]. The 13–93 fibers were kindly provided 
by Vivoxid Ltd. In publication V, monolithic samples, cut from the annealed glass 
blocks with a low-speed saw to dimensions 20 mm x 10 mm x 5 mm, were utilized to 
study the crystallization behavior of 1–98 and 13–93. 
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Figure 10. Glass particles (300-500 µm) before and after rinsing procedure with acetone 
3.2. Experimental techniques 
3.2.1. Inductively coupled plasma-optical emission spectrometry, 
ICP-OES (publications I-IV and VI) 
The ion concentrations in the solutions were measured using an inductively coupled 
plasma-atomic emission spectrometer, ICP-OES (Optima 5300 DV, Perkin Elmer). 
The instrumental conditions for Optima 5300 DV are summarized in Table 7. In 
addition, the detected wavelengths, limits of detection (LOD) according to the used 
software (WinLab32, Perkin Elmer), and estimated limits of quantification (LOQ) for 
the normal and the continuous measurements are shown in Table 8.  
Additionally, another ICP-OES instrument was utilized for ion concentration 
measurements in publications I and III (Thermo Jarrell Ash AtomScanTM 25, software 
ThermoSPEC 6.20). The elements and corresponding emission lines were the same as 
when using Optima 5300 DV. 
Table 7. ICP-OES Optima 5300 DV instrumental conditions 
Parameter Setting  Parameter Setting  
RF power 1300 W Read delay** 60 s 
Nebulizer flow 0.8 l/min Back-ground correction 2 points 
Auxiliary flow 0.2 l/min Auto integration 1 s min – 5 s max 
Sample pump flow 1.5 ml/min Rinse** 30 s 
Plasma viewing* axial Replicates** 3 
Viewing distance 15 cm (axial and radial) Spray Chamber Scott-type 
Processing mode peak area, Nebulizer cross-flow 
 3 points   
* Na and K additionally analyzed using radial viewing during non-continuous mode 
** Continuous mode read delay 2 s, rinse never, 1replicate 
 
Before After
Before After
10 µm10 µm
100 µm100 µm
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Table 8. Detected wavelengths, limit of detection (LOD) given by WinLab 32 software (Perkin 
Elmer), and the estimated limit of quantification (LOQ) values for conventional (publications 
I,III,VI) and continuous measurements (publications II and IV) 
Element Wavelength (nm) 
Ionization state 
I = neutral atom 
II= + 1 ion 
LOD 
(mg/l) 
 ~ LOQ 
(mg/l) 
~ LOQcont 
(mg/l) 
Si 251.611 I 0.0120 0.1 0.3 
Na 589.592 I 0.0690 0.5 1 
K 766.49 I NA 0.3 0.3 
Ca 317.933 II 0.0100 0.1 0.2 
Mg* 285.213, 279.077 II 0.0016 0.02 0.05 
P** 213.617 I 0.0760 0.1 0.3 
* Thermo Jarrell Ash 279.553 nm 
** Possible interference: Cu II 213.597 (relative sensitivity: Cu II 35000, P 5400) 
3.2.2. Scanning electron microscopy, SEM (publications I, III, V, and VI) 
The overall appearances and oxide compositions of the glass samples were studied by 
SEM-EDXA (Scanning Electron Microscope with Energy Dispersive X-ray Analysis, 
SEM, LEO 1530 from Zeiss, EDXA Ultra Dry by Thermo Scientific). All the samples 
were sputtered with carbon prior to the analysis. Furthermore, formation and thickness 
of different reaction layers was followed with SEM-EDXA from the cross-section of 
the samples. To establish the cross-section, the samples were embedded into epoxy, 
cut, and polished. The NSS 3.0.116 (Thermo Electron Corporation) software was 
utilized in the data analysis.  
3.2.3. X-Ray powder diffraction, XRD (publications V and VI) 
The phase composition of heat-treated samples was analyzed using X-ray diffraction 
(X’pert by Philips, Cu α radiation, 40 kV, 30 mA). The measuring range was 5–60° 2θ 
and the scan speed was 0.8° 2θ /min. The phase identification was done using the 
Philip X’Pert HighScore program equipped with Powder Diffraction File database 
Data Sets 1-49 plus 70-86 (ICDD 1999).  
3.2.4. Differential thermal analysis, DTA (publications IV and V) 
In publication IV, the glass transition temperature Tg was determined by Differential 
Thermal Analysis (Mettler Toledo TGA/SDTA851e). The experimental parameters 
were the same as used by Arstila [129]. The measurements were performed on 15 mg 
samples with the particle size < 45 µm in platinum pans in an N2 atmosphere with a 
heating rate of 20°C/min. The Tg was taken from the onset of the endothermic peak as 
in [129]. 
In publication V, the glass transition temperature Tg and the crystallization 
temperature Tp were determined by the same instrument as above at various heating 
rates (10, 15, 20, and 30°C/min). The measurements were performed on 50 mg 
samples with the particle size range 300–500 µm (Pt pans, N2 atmosphere). In this 
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study, the Tg was taken at the inflection point of the endotherm, obtained by taking the 
first derivative of the DTA curve and the Tp was taken at the maximum of the 
exothermic peak. The equations and procedures for the calculation the activation 
energy associated with the crystallization temperature, Johnson-Mehl-Avrami (JMA) 
exponent, and the nucleation-like curves are presented in detail in publication V. 
3.2.5. Hot stage microscopy, HSM (publication VI) 
The sintering behavior of S53P4 (size fraction < 45 μm) was studied using hot stage 
microscopy (HSM, Misura 3.0, Expert System). The heating rate was 40°C/min to 
480°C and then 5°C/min to 1200°C. A cylindrical sample (height 3 mm, diameter 2 
mm) pressed from the powdered glass was imaged after every 5°C increase in 
temperature. Based on these images, a sintering curve was plotted showing the height 
of the sample as a function of temperature. 
3.2.6. Micro-computed tomography, µCT (publication VI) 
The porosity of cylindrical implants sintered in publication VI was measured using 
micro-computed tomography, µCT (Skyscan 1072 micro-CT, Skyscan n.n.). The 
implants were cut into four sectors so that they would fit in the sample holder. Each 
sample was imaged with a step angle of 0.45° over a full range of 180°. The source 
voltage was 61 kV, the source current was 163 µA, and no filter was used. During 
image acquisition, a single 16 bit grayscale shadow projection image was obtained for 
each step angle without frame averaging. 
3.2.7. Standard crushing device (publication VI) 
The compression strength σ of sintered structures was measured with a standard 
crushing device (L&W Crush Tester, Lorentzen & Wettre). The rate of compression 
was 10 mm/min. The exact size of each implant was measured to calculate the 
compression strength per mm2.  
3.3. Conventional dissolution studies (publications I-IV, V) 
The glass dissolution in static, i.e. no flow, conditions was studied using two different 
methods. The first method was the conventional chemical durability test, ISO 719, 
designed for assessing chemical durability of commercial, rather durable, glasses. In the 
second method the glasses were immersed in buffered solutions at ambient 
temperatures, which is suitable for bioactive glass studies. Both of these methods are 
briefly described below. 
In addition to the concentrations values, normalized mass loss values were used in 
this work calculated according to equation 6: 
     
  
        
 , (6), 
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where ci is the concentration of the cation i in solution and fi is its mass fraction in 
the original glass, SA is the calculated surface area, and V volume of the solution [238, 
242]. The surface area was calculated assuming spherical particles with an average 
diameter of 400 µm and a density of 2.4 g cm-3. The specific surface area for the 300-
500 µm size range particles was calculated to be 62 cm2 g-1. The normalized mass loss 
values facilitate the comparison of the dissolution of the different elements from one 
glass to another, and also to some extent to compare experiments made in different 
conditions. 
3.3.1. ISO 719 (Publications II and III) 
The hydrolytic resistance according to ISO 719 is measured by the volume of HCl 
required for titration of the alkali extracted from 2 g of glass particles (300-500 µm). 
The particles were kept for 60 min in 50 ml de-ionized water at 98°C, and thereafter, 
25 ml aliquot of the obtained solution was titrated against 0.01 M HCl solution using 
methyl red as an indicator solution [243]. In addition to the standard, the pH of the 
solution was measured at room temperature (Mettler Toledo) before titration and an 
aliquot (10 ml) was saved for ion concentration analysis with ICP-OES. Hydrolytic 
resistance classification (HGB) is based on the acid consumption in the titration and 
given on a relative scale 1–5 (Table 9). The lower the HGB class is the better is the 
hydrolytic resistance of the glass. The sodium oxide equivalent is obtained from the 
following relationship: 1 ml of HCl with concentration 0.01 mol/l corresponds to 310 
µg of sodium oxide. 
To evaluate the temperature effect on the hydrolytic resistance, the same test 
procedure was repeated at 40, 60, and 80°C. The hydrochloric acid consumption 
values at different temperatures were fitted into the Arrhenius equation and the same 
equation was also used to determine the activation energy values for the initial 
dissolution rate for different elements NRi0 (Equation 7): 
        
 
    
   (7), 
 
where: NRi0 = initial dissolution rate for element i, K = constant, Ea,i = apparent 
activation energy for element i in J/mol , R = gas constant 8.314 J/(mol∙K), T = 
absolute temperature in K [242]. NLi calculated with equation 6 was converted to 
initial normalized rate (NRi0) by dividing with the duration of the experiment, one 
hour.  
Table 9. Hydrolytic resistance classes according to ISO 719 [243] 
V(HCl), [ml] HGB  V(HCl), [ml] HGB 
≤ 0.10 1  0.85–2.0 4 
0.10–0.20 2  2.0–3.5 5 
0.20–0.85 3  >3.5 >5 
 
- Materials and methods - 
 37 
3.3.2. In vitro test (publications I, III, and VI) 
The in vitro behavior of the glasses was studied using different immersion solutions 
which are summarized in Table 10. The source chemicals used in solution preparation 
together with their CAS numbers and producers are given in Table 11. 
Table 10. Inorganic ion concentrations of the human blood plasma and of the immersion 
solutions used in this thesis (mmol/l). In addition, the concentration of organic buffering agent 
(TRIS) is given. 
 c [mmol/l] 
Ion Blood plasma [206] SBF [246] Na-PBS Tris 
Na+ 142 142 156.2  
K+ 5 5   
Mg2+ 1.5 1.5   
Ca2+ 2.5 2.5   
Cl 103 147.8 100.9 45 
HCO3
 27 4.2   
HPO42
 1 1 24.9  
SO42
 0.5 0.5   
H2PO4
   5.5  
Tris  50  50 
Used in publication  I, VI I I, II, III, IV 
 
Table 11. Chemicals (p.a. grade), CAS numbers and producers 
Chemical CAS Producer 
C4H11NO3 (Trizma Base) 83147-39-1 Sigma-Aldrich 
CaCl2·2H2O 10035-04-8 Merck 
HCl (Titrisol 1M) 7647-01-0 Merck 
K2HPO4·3H2O 16788-57-1 Merck 
KCl 7447-40-7 Merck 
MgCl2·6H2O 7791-18-6 Merck 
Na2HPO4 7632-05-5 Merck 
Na2SO4 7757-82-6 Merck 
NaCl 7647-14-5 Merck 
NaH2PO4 7558-80-7 Merck 
NaHCO3 144-55-8 J.T. Baker 
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The experimental parameters for the in vitro test used are summarized in Table 12. 
The common features of the procedure used in all the conventional in vitro experiments 
are listed below: 
 The glass samples were carefully weighed in polypropylene beakers and the 
pre-heated immersion solution (37°C) was added on the glass sample 
 Beakers were kept in a thermostat at 37°C 
 pH of the solutions was measured periodically during the immersion 
(Mettler Toledo) 
 After immersion, the solution and the sample were separated 
 The samples were rinsed with ultra-pure water (Millipore) to remove 
residual salts, with ethanol/acetone to terminate the reactions 
 The final pH of each immersion solution was recorded after the separation 
 The immersion solutions were analyzed with ICP-OES 
 The solid samples were analyzed with SEM-EDXA 
Table 12. The parameters used in the conventional in vitro tests 
Sample  
mglass 
 (mg) 
Vsol 
(ml) 
immersion 
time (h) 
Static/ 
shaker 
Repeated 
samples 
Reference 
Particles (500–800µm) 1.5 ·103 15 1–336 static 3–6 I 
Fibers 
(Ø 20–140µm, length 2-3 cm) 
15 16 1-336 static 3–6 I 
Particles (315–500µm) 200 25 4 and 24 static 3–6 III 
Sintered porous implants 
(from particles 500–800µm) 
600 25 24 and 48 shaker 3–6 VI 
3.4. Continuous ion dissolution studies (publications II–IV) 
The early-stage chemical durability of the glasses was measured with a novel in vitro 
experimental setup developed in this work. In the setup, a flow-trough cell was 
connected directly to ICP-OES (Optima 5300 DV, Perkin Elmer). The ions dissolved 
from the glasses were recorded continuously. The duration of the experiments 
applying the continuous mode varied from 15 to 60 minutes. 
The schematic flow sheet of the system and the sample cell are shown in Figure 11. 
The cylindrical sample cell was filled with irregular glass particles, and a random 
packing of the particles was assumed. The solvent was fed with a peristaltic pump 
through a bed of glass particles so that it travelled upwards vertically through the bed. 
The flow rates were gravimetrically determined and were shown to be in the laminar 
region (Re′ <1 in all cases in Table 14). The ion concentrations were measured on-line 
every 12 seconds (one replicate per measurement). Furthermore, the pH values of the 
dissolution medium were recorded every 10 seconds with an otherwise similar setup 
except that the ICP-OES was replaced by a flow-through micro volume pH electrode 
(Konelab, Thermo Scientific). 
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The calibration was performed with ultra-pure water (Elga), and multi-element 
standards (diluted from Ultra Scientific RI) with concentrations of 1 ppm (K 10 ppm; 
Si 0.5 ppm) and 10 ppm (K 100 ppm; Si 5 ppm). It was always performed with the 
same flow parameters as those used in the sample concentration measurements. The 
stability of the calibration was controlled by measuring a standard solution sample 
between runs. The background level was recorded before each sample run, and all 
reported ion concentrations were background corrected. 
 
Figure 11. Schematic flow sheet of the continuous ion measurement system and the sample cell 
(II,III, and IV) 
The calibration of the pH meter was performed using the same experimental 
parameters as those for the ion concentration measurements, with two pH standards 
(pH 7 and 9). The stability of the pH standards was checked regularly with a static 
conventional pH meter (Mettler Toledo). 
The experimental parameters for the continuous measurements are collected in 
Table 13, where F is the flow rate and T the temperature. In one series 3 different 
sample size dimensions were tested (short, long, medium). Otherwise, a sample cell 
with the dimensions length 10 mm and diameter 5 mm was used (noted normal in the 
table) in the measurements. The sample mass normally used was 280 ± 5 mg with few 
exceptions (cf. Publication II). 
Table 13. Parameters used in the different experimental series using continuous in vitro test 
Experiment series  F (ml/min) Solvent T (°C) 
Sample 
cell 
Reference 
1 0.2 H2O 40 s, m, l* II 
2 0.08–0.8** H2O 40 normal II 
3 0.2 H2O 40, 60, 70, and 80 normal II 
4 0.2 H2O 40 and 80 normal III 
5 0.2 TRIS 40 normal II, IV 
* Short (dimensions), medium (dimensions), long (dimensions) **Listed separately in Table 14 
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Table 14 shows the superficial mass velocity based on the empty chamber cross 
section (G) and the modified Reynolds number for backed beds (Re′). The Re′ was 
calculated using the Equation 8:  
  e′ = DpG μ (8) 
 
where Dp is average particle diameter (m), defined as sphere, G fluid superficial 
mass velocity based on the empty chamber cross section (m/s), and μ fluid viscosity 
(m2/s) [277]. The fluid dynamic viscosity of water at 40°C is 6.59·10-7 m2/s.  
 
Table 14. Flow rate (F), fluid superficial mass velocity (G), and the modified Reynolds number 
(Re′) calculated according to Equation 1 (II) 
F (ml/min) G (cm/min) Re'  
0.08 0.4 0.04 
0.12 0.6 0.06 
0.2 1.0 0.10 
0.4 2.0 0.21 
0.8 4.1 0.41 
 
As in the case of conventional dissolution studies, the concentrations were 
converted into the normalized mass loss rates similarly to equation 6. Only, the volume 
of the solution (V) is changed to flow rate of solution in m3/s (F). 
3.5. Crystallization and sintering (publications V and VI) 
Crystallization and sintering behavior were studied using 1-98, 13-93, and S53P4 to 
gain more information regarding the suitability of these compositions for hot working. 
A preheated electric furnace was used both in crystallization (publication V) and 
sintering (publication VI) studies. Monolithic samples (20x10x5 mm3, publication V) of 
glasses 1-98 and 13-93 were heat treated in a graphite mould isothermally in the 600°–
1000°C temperature range for 10 min to 8 h. Porous implants were produced for 
publication VI by sintering irregular particles (500 to 800µm) of glass S53P4 at the 
same temperature interval for 1 h. The particles were put into cylindrical holes of 
different sizes in two graphite molds: i) Ø10 mm, height 5 mm; and ii) Ø 5 mm, height 
5 mm. 
All the samples were pushed into a preheated furnace with a nitrogen atmosphere. 
Recording of the time began when the temperature reached 95% of the target value; 
usually, this took around 15 min. The target temperature was maintained for the 
desired time, and then the samples were cooled rapidly in nitrogen flow to room 
temperature. The samples were stored in a desiccator prior to the analysis.  
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4. Results and discussion 
4.1. Conventional dissolution studies 
Below, the key results obtained using the traditional static in vitro testing (publication I) 
and the hydrolytic resistance values measured with ISO 719 (mainly publications II and 
III) are discussed. 
4.1.1. Glass reactions in different immersion solutions  
When a buffer solution is chosen for in vitro experiments, the objective and the nature 
of the tested materials need to be considered closely. Therefore, in publication I, glass 
reactions in three immersion solutions TRIS, SBF, and Na-PBS were studied and 
compared. The main driving force behind this study lies with the findings of a previous 
research project (Biowaffle, Tekes Finland) that was done in cooperation with TUT. 
During this project, bioactive glass fibers (1-98) embedded in a polymer matrix 
(P(L/D)LA and P(L/DL)LA) were found to dissolve completely and interestingly 
produce hollow HA tubes (Figure 12) [278]. Similar hollow structures in PBS have 
been reported earlier and are discussed by Rahaman et al. [40] in a review article. 
 
Figure 12. Bioactive glass polymer composite prior to immersion (right) and after two weeks of 
immersion in 50 ml Na-PBS [278] (Samples for SEM analysis were kindly provided by Mikko 
Tukiainen, TUT)  
The buffering systems available in the three immersion solutions together with pKa 
values are given in Table 15. In addition, logarithmic diagrams for the acid base 
equilibriums as a function of pH for the different systems at 25°C, calculated using 
principles demonstrated by Hägg [279] and Sillén [280], are given in Figure 13-Figure 
15. The preparation of SBF (composition is given in Table 10) is the most complicated 
of these three solutions and includes a high risk of precipitation during the preparation 
stage and storage. As can be observed from the table and Figure 15, in SBF different 
buffering systems are present whereas the two other solutions have only one system. 
The carbonate system, because of the atmospheric carbon dioxide, is excluded here 
from TRIS and Na-PBS. Na-PBS can be easily prepared by dissolving sodium chloride, 
monosodium phosphate, and its conjugate base disodium phosphate into ultra-pure 
water to generate pH values around 7 (pKa2=7.2). The effective buffering range of 
PBS is between 6.2 and 8.2. The pH of the solution is not sensitive to temperature 
changes in contrary to TRIS-buffered solutions. In comparison, the effective buffering 
range of TRIS (pKa=7.8 at 37°C) is between 6.8 and 8.8, which is the dominant 
100 µm
10 µm
- Results and discussion - 
42 
buffering system both in SBF and TRIS. It has been shown by titration that the 
buffering capacity of TRIS and SBF are similar [57]. This was verified by calculating 
theoretical titration curves with all the three solutions with CurTiPot software (version 
3.6.1 for MS-Excel 2007-2010) using 0.1 M strong base as a titrator. The buffering 
capacity of the initial solutions was also evaluated with the same program. The buffer 
capacity for an aqueous solution defines how much acid or base must be added to the 
solution to influence the pH. The buffer capacity can be calculated using eq. 9: 
   
   
     
  
   
     
 (9) 
 
,where Cb gives the concentration of the added base and Ca the concentration of the 
added acid [281]. The buffer capacity is an additive property and all the active 
components contribute to the buffer capacity [281]. The titration curves together with 
the calculated buffer capacity of the initial solutions are shown in Figure 16. 
Table 15. Available buffering systems in the immersion solutions together with the acid 
dissociation constants , pKa (values from [282, 283]) 
Buffering system pKa (25°C) Solution 
(HOCH2)3CN+H3 (aq) ⇌ H+(aq) + (HOCH2)3CNH2 (aq) 8.06 # SBF, TRIS 
H3PO4 (aq) ⇌ H+(aq) + H2PO4-(aq) 
H2PO4-(aq) ⇌ H+(aq) + HPO42-(aq) 
HPO42−(aq) ⇌ H+(aq)+ PO43−(aq) 
2.16 
7.21   (pKa2) 
12.37 (pKa3) 
SBF, Na-PBS 
H2CO3*(aq) ⇌ H+(aq) + HCO3-(aq) 
HCO3− (aq) ⇌ H+ (aq) + CO32− (aq)  
6.37 
10.32 (pKa2) 
SBF 
# ∆ Ka/°C = -0.027, H2CO3* is used here to represent both dissolved CO2 and H2CO3 
 
The high initial phosphate concentration of Na-PBS gives a fast precipitation when 
calcium species are added to the solution and is likely to increase the dissolution rate of 
bioactive glasses. This questions the suitability of studying bioactivity in Na-PBS. In 
this study, in vitro reactions of four bioactive glasses were followed. Glasses 45S5 and 
S53P4 were tested as granulates (500-800 µm), whereas glasses 13-93 and 1-98 were 
tested as fibers (dfiber 20-140 µm). 
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Figure 13. Logarithmic diagram for the acid base equilibrium as a function of pH for TRIS-buffer 
system at 25°C, calculated using principles demonstrated by Hägg [279] and Sillén [280] and 
using 50 mM as the total concentration [R-CN+H3]+[R-CNH2]. 
 
Figure 14. Logarithmic diagram for the acid base equilibrium as a function of pH for H3PO4 
system at 25°C, calculated using principles demonstrated by Hägg [279] and Sillén [280] and 
using 30.4 mM as the total concentration of [H3PO4]+ [H2PO4-]+[HPO42-]+[PO43-]. 
 
Figure 15. Logarithmic diagram for the acid base equilibriums as a function of pH for TRIS, 
H3PO4, and H2CO3* system at 25°C, calculated using principles demonstrated by Hägg [279] 
and Sillén [280] (the total concentrations: [R-CN+H3]+[R-CNH2] = 50 mM, [H3PO4]+ 
[H2PO4-]+[HPO42-]+[PO43-] = 1 mM, and [H2CO3*]+ [HCO3-]+[CO32-] = 4.2 mM). 
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Figure 16. Theoretical titration curves for the three solutions used in publication I calculated with 
0.1 M strong base as a titrator and the buffer capacity of the solutions using CurTiPot software 
Figure 17 shows the pH increase of the three immersion solutions for the four 
glasses. 45S5 and S53P4 undergo a rapid ion-exchange reaction, and already after four 
hours of immersion the effective buffering range of Na-PBS has been passed. After 
this point, pH continues to increase to similar levels as with the unbuffered solution, 
water (data given in publication I). The pH increase stabilizes to values near the pKa3 
for H3PO4. The overall increase of pH was lower with the fiber samples as with 
granulates; this was also expected because of two reasons: the different SA/V 
relationship, and the different reported reactivity of the glass compositions [130]. Both 
fiber compositions follow the same trends, even though the actual values of 1-98 and 
13-93 cannot be directly compared because of the 13-93 fibers were coated. It could be 
concluded from the pH results both with granulates and fibers that SBF could 
maintain pH close to the original for a much longer time than Na-PBS. 
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The high pH in Na-PBS gave partly increased glass dissolution, but also faster CaP 
formation as was verified with both ion concentration and SEM measurements. 
However, under these experimental conditions no hollow structures were obtained 
with any glasses. Figure 18 shows the oxide composition of 13-93 fiber surfaces at 
different time points. Clear differences in the different solutions in the layer formation 
can be observed. The time scale of layer formation differed, and the composition of 
the formed layers showed differences. 
This study verified that the choice of immersion solution and conditions at the 
immersion are highly important. In TRIS and SBF, the initial ion dissolution was 
found to be similar. For 45S5 and S53P4, a three layered structure, consisting of silica 
rich, mixed (Si+CaP), and CaP layers, was observed in both solutions. However, 
differences in the layer formation in these two solutions were observed with 1-98 and 
13-93. In TRIS, no or only sporadic CaP layer formation was noticed. This was 
probably because of the low amount of phosphorus present in the original glass 
compositions. In SBF the three layered structure was observed. Depending on 
experimental conditions, Na-PBS led to faster glass dissolution or CaP layer formation 
due to the initial high phosphorus content in the solution and the lower buffer capacity 
than TRIS and SBF. Hence Na-PBS testing can give misleading information on the 
bioactivity of the glass. 
The trends observed in the reactivity of the glasses in the different solutions can be 
used when comparing experimental results in one of the solutions with reported 
observations of the same glass in the other solutions. However, care should be taken 
when such comparisons are made because also other experimental parameters affect 
the in vitro test outcome. 
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Figure 17. pH change in SBF, TRIS, and Na-PBS, ΔpH <0.05 pH unit if error bars not presented 
(A: 45S5, B: S53P4, C: 1-98, D: 13-93) [publication I] 
 
 
Figure 18. EDXA of the oxide composition on the 13-93 fiber surfaces. (A: TRIS, B: SBF, and C: 
Na-PBS). The SEM-image (1.5kx) shows the surface after 120 h in Na-PBS. [publication I] 
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4.1.2. Hydrolytic resistance 
One of the objectives of this thesis was to test the suitability of different methods for 
obtaining fundamental information on glass dissolution at different experimental 
conditions. As discussed in chapter 2.3.1, hydrolytic resistance correlates with the 
reactivity of glasses, and eventually also with their bioactivity. Thus, hydrolytic 
resistance was also considered. Bioactive glasses have earlier been found to dissolve 
readily, potentially exceeding the relative scale given in the standard [55, 284]. 
Nevertheless, hydrolytic resistance might give relevant data when testing slowly 
dissolving glasses for biomedical applications which are closer to typical SLG than 
bioactive glasses. 
The ISO 719 standard method does not take into account the pH of the solution 
before the titration. However, pH has been shown to increase to values above 9 with 
several tested glass compositions [55, 284]. This implies that the acid consumption 
does not depend only on the alkali extraction but is also affected by dissolution of the 
glass network, typically taking place for silicate glasses above pH 9 [200]. Thus, pH 
measurements together with ion concentration measurements were added to the 
standard procedure. The hydrolytic resistance results are mainly discussed in 
publication III, but also in publication II. The hydrolytic resistance of the glasses used 
in publication IV has only been discussed previously in an oral presentation given by 
the author (2012) [285], but the data is also included here to allow correlations to be 
made with the results presented in publication IV. 
Table 16 summarizes the hydrolytic resistance values of all the glasses. The 
hydrolytic resistance is given as the consumption of hydrochloric acid according to 
ISO 719 together with the pH values of non-titrated solutions measured at room 
temperature. In addition, hydrolytic resistance values measured at different 
temperatures, but otherwise following the standard, are also given. 
E-glass showed a medium resistance, glass 45S5 a very low resistance, while the 
other glasses had values in between. Similar results for float glass can be found in the 
literature [286, 287]. Also hydrolytic resistance of 13-93 is of the same order as 
reported by Brink [55]. The average pH values of the solutions at room temperature 
were all higher than 9, except for E-glass at lower temperatures. The decomposition of 
the glass network and the ion-exchange reaction were verified by the concentration of 
the ions dissolved from the glasses (Table 17). The ion concentrations in the solutions 
were converted to normalized surface-specific mass loss. At 98°C the ion-exchange 
reaction was dominating for all compositions. 
The relative scale fails to give any relevant information when bioactive glasses are 
studied. However, the differences in the hydrolytic resistance values imply that the 
method could be used as a rapid test to get an overall idea of the biodegradability of 
the glasses. As can be seen from the table, the high silicon concentrations released 
from the glasses decrease the volume needed in the titrations. Thus, the ion 
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concentration measurement together with the pH values gives a better estimate of 
hydrolytic resistance. 
Both hydrolytic resistance and Tg are dependent on the mobility of the modifying 
ions. Interestingly, when these two values for glasses are plotted against each other, a 
preliminary correlation can be seen (Figure 19). In addition, it seems that all the glasses 
forming wollastonite (CS) as a primary crystal phase have higher hydrolytic resistance 
than glasses forming sodium calcium silicate (NCS) crystals. It would be of interest to 
elaborate on this further to see whether a true correlation can be obtained. 
Table 16. Hydrolytic resistance (ISO 719) given as consumption of HCl [ml] per gram of glass 
grains at different temperatures, %RSD given for glasses with number of titrated samples ≥ 6. 
Glass 
code 
T  V (HCl)  
% 
RSD 
pH 
(RT) 
Ref.  
Glass 
code 
T  
V 
(HCl)  
% 
RSD 
pH 
(RT) 
Ref. 
 [°C] [ml/ g glass]      [°C] [ml/ g 
glass] 
   
E-glass 40 0.04  8.3 III 
 
 45S5 25 1.1  10.2 III 
60 0.1  8.4  40 2.1 2 10.3 
80 0.2  9.0  60 2.3 8 10.5 
98 0.3 3 9.2  98 5.3 4 10.8 
             
Table 
ware 
40 0.1 21 9.4 III  1-98 
  
40 0.5  10.1 II 
 60 0.3 4 9.4    60 0.8  10.0  
 80 0.5  9.8    98 2.3 4 10.2  
 98 0.8 4 9.8         
             
Float 40 0.2 4 9.5 III  DGG1 98 1.0 1 9.9 III 
 60 0.2 8 9.5         
 80 0.5 10 9.8         
 98 1.0 4 9.8         
             
0106 98 2.1  10.0 [285]  1306 98 2.7 9 10.4 [285] 
0206 98 2.7 12 10.3 [285]  1406 98 1.4  9.8 [285] 
0306 98 3.9  10.6 [285]  1606 98 1.2 20 9.7 [285] 
0906 98 1.5  10.1 [285]  1806 98 2.3  10.1 [285] 
1106 98 1.7 8 9.9 [285]  13-93 98 2.7  10.7 [285] 
       S53P4 98 3.4  10.7 [285] 
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Table 17. Average ion concentrations in solution after one hour at 98°C (ISO 719), the same 
references apply as given in Table 16. For selected glasses error given as %RSD  
 
 Na 
(mg/l) 
K 
(mg/l) 
Mg 
(mg/l) 
Ca 
(mg/l) 
Si 
(mg/l) 
Hydrolytic resistance class 3: 
E-glass 0.4 0.5 0.1 3.1 4.3 
%RSD 13 15 20 7 6 
Tableware 6.0 2.8  0.4 10.4 
%RSD 2 5  33 2 
Hydrolytic resistance class 4: 
DGG 1 7.9 1.0 0.2 1.5  12.0 
%RSD 1 43 2 4 4 
1606 2.0 6.7 0.0 4.0 20.7 
1406 2.4 7.8 0.2 8.6 18.9 
Float 10.2 0.2 0.1 4.3 29.3 
%RSD 6 20 7 9 5 
0906 6.1 15.7 4.1 26.5 43.2 
1106 3.2 13.3 0.0 10.8 27.0 
Hydrolytic resistance class 5:  
0106 7.8 23.9 2.8 21.6 35.7 
1-98 6.2 11.0 0.3 12.8 28.3 
1806 13.3 1.7 0.0 5.1 23.4 
1306 19.3 3.3 0.1 4.6 21.6 
0206 11.8 16.8 0.1 8.9 25.2 
13-93 6.5 13.2 0.3 11.1 29.1 
S53P4 30.9 0.3 0.0 4.2 18.7 
Hydrolytic resistance class > 5 i.e above the scale: 
0306 26.3 2.9 0.1 4.3 18.2 
45S5 41.9 0.3 0.0 8.0 27.5 
%RSD 9 16 31 10 4 
* The missing value clearly under LOD 
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Figure 19. Correlation between Tg and V(HCl), data collected from [129, 131, 244] and publication 
IV, CS  = wollastonite, NCS = sodium calcium silicate. For Andersson et al. no primary crystal 
data available. 
The ISO 719 test procedure was applied at lower temperatures to determine the 
temperature effect on glass corrosion: as expected the lower the temperature the lower 
was the dissolution tendency (Table 16). At static conditions, the dissolution rate 
increased according to the Arrhenian behavior (discussed both in publication II and 
III). Arrhenius plots, i.e. the volume of HCl (ml) as a function of the inverse of 
temperature are shown in Figure 20. The plots are linear with similar slopes. 
Apparent activation energy can be used to determine the dissolution control 
mechanism. Diffusion controlled processes have commonly been assigned a low 
energy barrier with Ea in the range of a few kJ/mol, while surface reactions give rise to 
an higher barrier of around 80 kJ/mol [190]. The apparent activation energy, based on 
hydrochloric acid consumption, was between 21 kJ/mol (45S5) and 33 kJ/mol (E-
glass). This suggests that the dissolution was diffusion controlled for all the glasses. 
Also, the apparent activation energy values for the release of sodium (13-26 kJ/mol) 
and calcium (11-27 kJ/mol) would suggest the same. However, the apparent activation 
energy values for silicon dissolution from E-glass and float glass are high. This implies 
that for these glasses, the reaction mechanism is surface controlled. For the non-
durable bioactive glasses the apparent activation energy values for silicon dissolution 
suggested diffusion control. The ISO 719 method performed at different temperatures 
and combined with pH and ion concentration measurements gave also a possibility to 
estimate the reaction mechanisms. 
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Figure 20. Arrhenius plot of the volume of hydrochloric acid, V(HCl), consumed in titration after 
one hour. (publication III) 
4.2. Continuous dissolution studies  
In publication II, a sensitive on-line analysis method utilizing an inductively coupled 
plasma optical emission spectrometer and a flow-through micro-volume pH electrode 
was developed to study the initial dissolution of bioactive glasses. The developed 
method was utilized to study the initial dissolution reactions of highly different types 
of glass composition in publications III–IV and [284]. 
The novelty and strength of this method is that all the ions can be measured 
immediately after the reaction and followed simultaneously both qualitatively and 
quantitatively. To the best of the author’s knowledge, this type of approach has not 
been applied for studying glass dissolution reactions. In addition, in many studies the 
solution is circulated and thus the composition of the solution changes. In our 
approach, fresh solution with constant initial composition is continuously fed to the 
sample cell. 
The impulse response of the system was studied using yttrium. No significant 
impulse broadening because of the glass particle bed was observed and the ion release 
from the glass started as soon as the solution came into contact with the sample 
(publication II). One example of the initial ion dissolution graph obtained with the 
method is shown in Figure 21 for glass 1–98 in contact with ultra-pure water. The 
time-lag before the solution flow from the sample cell reached the ICP detector was 
around 140-180 s depending on the tubing length. The concentration peaks around 
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this time indicated high initial dissolution of alkalis. The smooth increase of silicon 
concentration in the beginning of the measurement suggests that the alkali ion peaks 
were not caused by uniform dissolution of glass, but depended on the ion exchange 
reaction with hydrogen in the solution. Usually, the derivatives of the curves 
approached zero around 400 s, suggesting that steady-state leaching conditions were 
reached. 
 
Figure 21. An example initial dissolution profile of 1-98 in contact with ultra-pure water, the error 
bars give the representative simple standard deviation for the measurements (publication II) 
4.2.1. Effect of various parameters on the initial dissolution profile 
The novel method was tested by measuring the effect of flow rate, temperature, and 
solution composition, among others, on the initial dissolution behavior of bioactive 
glass 1-98 consisting of several oxides (publication II). This study was performed to 
validate whether similar trends are gained with this method as with conventional 
studies. In addition, this study was important for choosing suitable parameters for the 
following studies. The key observations from the effect of the different parameters on 
the initial glass reaction are listed in Table 18.  
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Table 18.Effect of various parameters on the initial reactions of glass in contact with aqueous 
solutions (publication II) 
Parameter Key observations 
Surface area and 
sample mass 
 Studied using two particle size fractions. 
 For the size fraction 315–500 μm the initial top peak concentrations of 
potassium and sodium correlated almost linearly with the sample mass but 
for size fraction 62-125 μm no clear correlation with the sample mass and 
initial top peak height was observed 
o Several parameters affected the available effective surface area: 
fine powder attached to the glass particles, variations in the 
particle shape, size distribution of the particles, and packing of 
the particles in the sample cell. These may cause a large difference 
between initial real and calculated surface areas. Detailed attempts 
at correlating different size fractions were not included in this 
work 
 Results suggest that surface area was not the dominating parameter that 
controls the dissolution. The most important single parameter is probably 
the solution pH. 
 Changes in the effective surface area with proceeding dissolution may also 
have contributed to the observed non-linear dissolution trend between the 
samples with different masses. 
 
Particle bed 
dimension 
 Studied using three length and diameter combinations (L/Ø in mm 
18.0/3.2, 11.8/4.0, and 6.3/5.0), constant flow, temperature, and sample 
mass. 
 Induced no significant differences in the initial ion dissolution profiles. 
 Conditions inside the sample cell were assumed to remain constant, 
regardless of the bed height, for a certain flow and temperature 
 
Flow rate  Studied using five different flow rates between 0.08-0.8 ml/min and 
constant temperature 40°C. 
 Flow was laminar with all the tested flow rates 
 Over the whole flow rate range studied, the initial profiles did not change 
their overall form 
 Dissolution was uniform, within the experimental accuracy at all the 
measured flow rates 
 When using the highest flow rates of water, the dissolution rate changed 
from a diffusion-controlled towards a surface-controlled mechanism. 
 
Temperature  Studied using 40°, 60°, 70° and 80°C and constant flow rate (0.2 mL/min). 
 As a result of the temperature increase, the overall dissolution increased 
according to Arrhenian behavior (24-36 kJ/mol) and led more rapidly to 
steady state dissolution. 
 A clear decreasing trend in magnesium and phosphorus concentrations at 
higher temperatures was observed. 
o Back-precipitation (solubility of Mg(OH)2 decreases with 
temperature)  
o Complexation to silica gel is considered possible [288]  
 
 Table 18 continues on the next page. 
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Parameter Key observations 
Solvent 
composition 
 The change of solution from unbuffered (ultra-pure water) to TRIS-
buffered solution changed the dissolution mechanism from uniform to 
preferential (example graph shown in Figure 22). 
 Higher concentrations of all ions were measured in TRIS than in pure 
water. 
 
All the obtained trends and results were in agreement with results obtained with 
conventional dissolution studies. Thus, the results indicate that the method enables on-
line qualitative and quantitative analysis of the ions dissolving from glasses. The 
method developed is sensitive and promising for rapid screening of the dissolution 
mechanism of glasses in different experimental conditions. Even though only silica-
based glasses were studied within this thesis work, the method would also be suitable 
for studying the dissolution of other glass systems. In the future it would be interesting 
to compare the results obtained with this continuous method with results obtained 
with different type of simulation tools such as Monte Carlo models. Recently, Monte 
Carlo simulations have been successfully used to predict glass dissolution reaction 
mechanisms in near-equilibrium conditions in a flow environment for borosilicate 
glasses [289].  
 
 
Figure 22. Initial dissolution profile of 1-98 (0.2 mL/min, 40°C) in TRIS and in ultra-pure water 
(publication II)  
4.2.2. Dissolution patterns of biocompatible glasses in TRIS  
In publication IV, the initial dissolution of 16 glasses in TRIS was recorded in a flow 
environment to give time-dependent dissolution profiles. TRIS was selected as the 
immersion solution because it has a suitable buffering range and does not contain any 
ions that may interfere with the ICP-OES measurement of ions dissolved from the 
glasses. Furthermore, as was observed in publication I, the initial dissolution behavior 
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in SBF and TRIS is highly similar. The same sample cell as used in publication II was 
utilized, and flow rate (0.2 ml/min) and temperature (40°C) were kept constant during 
all the measurements. In addition, the sample mass was kept constant because no 
accurate surface area measurements were available. Still, it is noted that the dissolution 
reactions are surface area-dependent, and that the estimation to use the same calculated 
surface area for all the glasses is a possible source of error in the normalization 
procedure. For more accurate analysis of the data, the density of each glass as well as 
the real initial surface area should be used in the future. When assuming a constant 
glass density, a roughly 10-% error is inflected on the results through the surface area 
calculations. 
 
Figure 23. Four typical initial profiles for the experimental glasses (publication IV) 
The dissolution behavior of the glasses could be fitted into four profiles (A-D), 
which cover all the dissolution patterns obtained in this work (Figure 23). The detailed 
description of each patter is given in publication IV. 
The ion dissolution rates of the glasses were compared using the normalized 
surface-specific mass loss rate NRi (gm-2s-1). Based on the NRi values, all the glasses 
show preferential alkaline and alkaline earth ion dissolution in TRIS. The dissolution 
rates for these elements are of the same order, even though the values for alkaline 
earths are slightly higher than those for the alkalis. This may be due to rapid alkaline 
earth ion complexation with TRIS [257], which favors further dissolution. 
The role of phosphorus in the structure of silica-based glass has been studied by 
Lockyer et al., Elgayar et al., Tilocca et al., O’Donnell et al., and Pedone et al. [138, 
142, 145, 147, 150, 153], who suggested that P2O5 is present as an orthophosphate 
species rather than as a component in the silica network. In the presence of 
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orthophosphate, cations such as Na+ and Ca2+ are needed to maintain the charge 
balance [147]. It is likely that the high initial dissolution rate of phosphorus is due to 
the solubility of orthophosphate species. Specifically, sodium orthophosphate is highly 
soluble when exposed to water [147]. Thus, during the initial dissolution, 
orthophosphate species may have an important influence on the rate at which calcium 
phosphate (CaP) forms on the glasses. Although NRP values based on phosphorus 
concentrations close to LOQ must be treated with some caution, the phosphorus 
dissolution rate for most of the glasses is of the same order as the alkaline earth 
dissolution rate. As a clear exception, for 45S5, the NRP is of the same order as the 
NRSi. However, because it has been shown that in 45S5 P2O5 is present as 
orthophosphate species [145, 153], this discrepancy needs to be investigated in future 
studies. 
The normalized surface-specific mass loss rates and the steady-state concentrations 
were compared with reported in vitro and in vivo behavior of the glasses [30, 34, 48, 131, 
273, 274]. In addition, the hydrolytic resistance of the glasses, given in Table 16, was 
compared with the results obtained with the continuous measurements. The key 
observations and similarities of each pattern have been collected in Table 19, and in 
addition one of the in vivo model correlations is shown in Figure 24.  
Table 19. Key observations of the different patterns A-D  
Pattern Key observations 
A = bioactive glasses  high initial dissolution 
 poor hydrolytic resistance 
 rapid Si and CaP layer in vitro  
 bond to bone 
 crystallize easily 
B = ”medium” bioactive  
 
o noticeable but clearly lower ion dissolution 
o poor hydrolytic resistance 
o medium Si and CaP layer in vitro  
o bond to bone but slower 
o allow hot working 
C = biodegrable  Slow release of ions 
 medium to poor hydrolytic resistance 
 no distinct layers after 72 h in vitro 
 no bone bonding 
 variable hot working properties 
D = “inert” o sharp alkali dissolution peak 
o good to medium hydrolytic resistance 
o no distinct layers after 72 h in vitro 
o no bone bonding 
o good hot working properties 
 
In Figure 24, the normalized mass loss rate and the calcium and silicon 
concentrations are compared with the in vivo reaction number (RN) calculated using 
the model by Andersson et al. [34]. This model gives a relative value that can be 
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correlated with the reactivity of the glass in vivo: an RN of 1 implies that the glass is 
nearly inert; glasses with RN > 5 exhibit bone bonding and CaP formation; and 
intermediate values correspond to limited layer formation and no bone bonding. The 
model excludes the oxides of potassium and magnesium, and thus approximations are 
required to calculate the RN for the experimental glasses. In this work, we used the 
same approximations as those suggested by Brink [30], who replaced the amount of 
Na2O in the RN model with the total amount of alkali (Na2O+K2O), and the amount 
of CaO with the total amount of alkaline earths (CaO+MgO) [30]. 
The dissolution rate in the continuous flow-through reactor was consistent with the 
in vitro and in vivo reactivities of the glasses studied. Glasses that bond to bone, but 
crystallize easily under hot-working conditions show high initial dissolution of Na, Ca, 
and Si. The compositions that allow hot working and bone bonding exhibit noticeable, 
but clearly lower, ion dissolution profiles. However, ion dissolution can also be 
measured for glasses that are likely to dissolve slowly in buffered solutions, and low 
initial concentrations were recorded for glasses that are nearly inert in the body 
environment. 
Initial ion dissolution behavior in continuous fluid flow seems to provide an 
innovative and fast approach for pre-screening the suitability of different glass 
compositions as materials for bioactive, biodegrading, and bioinert medical devices. 
 
Figure 24. c(Ca)t=1000s, c(Si)t=1000s, normalized mass loss rate for calcium (NRCa), and normalized 
mass loss rate for silicon (NRSi), plotted as functions of in vivo reaction number (RN). The RN 
model and its standard deviation are taken from [34]. The same approximations to the RN model 
were used as suggested by Brink [30]. The lines are drawn to guide the eye. (publication IV) 
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4.3. Combining information from conventional and continuous studies 
By combining information from various experimental conditions, a better picture of 
glass dissolution and the suitability of the glasses for different medical applications can 
be obtained. Chemical durability of silicate glasses was tested in water and TRIS-
buffered solution at static and dynamic conditions at different temperatures. In all 
experimental conditions, the dissolution order of the glasses was the same. 
At dynamic conditions in water at 80°C, the soda-lime glasses dissolved uniformly 
while preferential dissolution was observed with E-glass. For the compositions studied 
in publication III, steady state dissolution conditions were approached after fifteen 
minutes. Measuring simultaneously all the ions released from the glasses gave a 
possibility to quantify the dissolution rate. This method was found suitable for 
compositions within a large range of chemical durability. 
In the static TRIS-buffered solution, only the bioactive glasses have been observed 
to dissolve readily (publication III). Thus, in the buffered solution no marked 
differences between the more durable glasses were observed. However, at the dynamic 
conditions with TRIS a sharp initial dissolution peak for alkali metals was observed, 
after which all measured concentrations decreased to near or under the limits of 
quantification. This suggests preferential alkali extraction during the first minutes of 
dissolution. However, the extent of extraction was too low to cause any essential 
changes in the solution pH. The low pH does not favor additional network dissolution. 
However, clear differences in the hydrolytic resistance of these glasses could be 
obtained.  
4.4. Crystallization and T-T-T for 1-98 and 13-93 
Publication V reports the crystallization characteristics of bioactive glasses 1–98 and 
13–93, and gives information on the T-T-T behavior in thermal treatments. The 
working ranges of both glasses are close to or partly within the temperature region in 
which they show high tendency to crystallize [45, 128]. The number and size of the 
crystals in heat treatment depend on the degree of overlapping of the nucleation and 
crystal growth domains. Both of these regions were estimated with DTA. 
The obtained results are presented together with the measured viscosity values for 
the glasses by Vedel et al. [128] in Figure 25. The calculated nucleation domain for 1–
98 was broader and possessed a higher amplitude than 13–93. The temperature of 
maximum nucleation (Tn max) was measured for glass 1-98 at 725ºC and for 13–93 at 
700ºC. The differences in the Tn max suggest that the nucleation rate for 1–98 is one 
order of magnitude higher than for 13-93. Even though the nucleation-like curves do 
not give the actual nucleation rates, these can be used as a good estimate of the actual 
ones. According to both DTA and isothermal heat-treatments, the crystallization of 1–
98 and 13–93 was found to commence around 800°C and it started from all surfaces, 
as confirmed by the optical microscope images. At this temperature, the thermal 
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properties clearly changed and the samples shape deformed (publication V). The upper 
limit for the crystallization range is characterized by the liquidus temperature where the 
formed crystals start to melt. This was estimated with DTA to take place around 1150-
1250°C confirming the results obtained by Arstila et al. [49]. 
The JMA parameter “n”, which is related to the growth dimensionality in 
crystallization, was close to 1 for both glasses in agreement with the observed surface 
crystallization. In addition, the activation energy for the crystallization of both glasses 
was of the same order (280 kJ/mol). This suggests that the primary crystalline phase is 
identical for both compositions, as was also verified by XRD and SEM analyses. The 
identified primary crystalline phase was wollastonite (CaSiO3) as reported earlier by 
Arstila et al. [129]. 
 
Figure 25. Nucleation and crystallization domain for the glasses obtained using DTA (Data 
publication V). In addition, the measured viscosity values for the glasses are given [128].  
The typical viscosity values utilized in sintering and fiber drawing of glasses are 
108–5·108 dPa·s and 103–5·103 dPa·s, respectively. The fiber drawing values coincide 
with the crystallization range (Figure 25). However, in practice if the crystal growth 
rate below the liquidus temperature is low enough, limited glass processing can still be 
performed. To estimate the average crystal growth rate (Uaverage) for the glasses 
isothermal heat-treatments were performed. Albeit being a laborious approach it gave 
valuable information about the differences in the crystallization rates. In the studied 
temperature interval, the crystal layer thickness as a function of time was found to be 
highly linear. The average crystal growth rate was estimated by plotting the slopes from 
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the time dependent curves versus temperature. The dependency was found to be 
exponential as a function of temperature. The values are given as arithmetical means 
with error bars indicating the minimum and maximum values. 
Equation 10 for glass 1-98 and Equation 11 for glass 13-93 were formulated based 
on the experimental results:  
   μ    
 
 
                       (10) 
   μ    
 
 
                        (11) 
 
where X is the crystal layer thickness, t time, and T temperature. The equations can 
be used to estimate the crystal layer thickness as a function of the heat treatment time 
and temperature. It should be observed that they are valid only in the studied 
temperature interval; at higher temperatures, a decrease in the crystal growth is 
expected. The crystal layer thicknesses calculated with Equations 10 and 11 are drawn 
as functions of both heat treatment time and temperature in a 3D plot in Figure 26. 
The figure clearly illustrates the large difference in the crystal growth rate for the two 
glasses. 
 
Figure 26. Crystal growth as a function of time and temperature using the Equations 10 and 11 
(publication V) 
According to the SEM images, it appears that the crystal layer thickness should be 
around 100 µm to cover the entire sample surface. This value was used as a boundary 
between conditions for crystalline and amorphous phases when drawing the 
approximate T-T-T curves in Figure 27. Thus, at conditions below the lines, the glasses 
do not crystallize, while at conditions above the lines, crystallization is expected to take 
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place. In the same figure, the experimental values from Arstila et al. [290] for 
crystallization of particles (500-800 µm) of glass 1-98 are given. 
A good correlation can be found between the values reported for crystallization of 
the particles and the obtained T-T-T curve for 1-98 [290]. The T-T-T curve suggests 
that monolithic samples or large particles of 1-98 can be heat-treated below 800°C for 
several hours and below 850°C for at least 20 min before they start to crystallize. 
Within 800-850°C, the viscosity of the melt is low enough to allow viscous flow 
sintering into porous bodies [45]. However, in the temperature range from 850 to 
1000°C, the melt crystallizes easily. The T-T-T curves suggested can be used estimate 
to the parameters for glass processing within the temperature range from glass 
transition up to liquidus. 
The information gained is essential in manufacturing amorphous porous implants 
or drawing of continuous fibers of the glasses. Although both glasses can be hot-
worked to amorphous products at carefully controlled conditions, 1-98 showed one 
magnitude greater crystal growth rate than 13-93. Thus, 13-93 is suited better than 1-98 
for working processes which require long residence times at high temperatures. The 
more rapid crystal growth rate in 1-98 than 13-93 explains partly the reported 
differences in the fiber drawing properties of the glasses with preforms [49]. When 
fibers were drawn below the liquidus, 1-98 crystallized faster than the 13-93. The slow 
growth rate in 13-93 allowed for manufacture of continuous fibers, while crystallization 
faster prohibited the fiber drawing from 1-98 In addition, when the fiber drawing is 
done with a preform, the glass passes through the nucleation range affecting the fiber 
drawing success. 
  
Figure 27. T-T-T graph calculated using the Equations 10 and 11. Threshold between glass and 
crystal layer in the T-T-T graph assumed 100 µm (publication V) 
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4.5. Sintering of porous implants of S53P4 
In publication VI the influence of sintering temperature on the in vitro reactivity and 
mechanical strength of porous implants made of S53P4 was investigated. In general, 
the mechanical strength of the porous glassy implants is poor, although it improves 
with higher sintering temperature. Unfortunately, higher sintering temperature also 
increases the amount of crystallization, and if crystallization occurs too rapidly, it 
interferes with viscous flow sintering. Accordingly, to be able to sinter scaffolds from 
powdered fractions of bioactive glasses, it is essential to acquire a detailed 
understanding of the high temperature properties and crystallization mechanisms of 
the glasses. Then, a convenient heat treatment with suitable time and temperature 
parameters can be designed. The crystallization behavior of S53P4 has been studied 
earlier [129, 163, 217, 291], and the results relevant for heat treatments are collected in 
Figure 28. 
As suggested by the figure, amorphous implants could be sintered below 650°C. 
But, below this temperature the viscosity was too high to allow proper strengthening 
of the implants during the 1 h sintering time (c.f. Figure 28). Furthermore, in 
accordance with the literature [129, 291], surface crystallization of S53P4 was observed 
to start at 650°C by formation of Na2O∙CaO∙2SiO2 crystals (PDF 01-077-2189). Rapid 
heating to temperatures higher than 800ºC produced fewer but larger primary crystals 
and a greater amount of residual glassy phase. The highest volume fraction of crystals 
in the surface layer formed at 800°C. Thus, nucleation and the number of crystals were 
highest at around 800ºC, while crystal growth dominated at the higher temperatures. 
 
Figure 28. Nucleation [217] and crystallization domain for S53P4 obtained using DTA and 
isothermal heat treatments (publication VI). In addition, the measured viscosity values for the 
glasses are given [128]. 
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As a novel finding, secondary crystals of Na2Ca4(PO4)2SiO4 (PDF 00-032-1053) 
were detected at higher temperatures, from 850°C to 1000°C. In the thermal treatment 
of 45S5, the phosphate-rich glassy phase that forms around larger crystallites of 
primary Na2CaSi2O6 is thought to catalyze the formation of secondary 
Na2Ca4(PO4)2SiO4 crystals [292]. In this work, most of the secondary crystals were 
found in the vicinity of the primary crystals, suggesting that secondary nucleation 
occurs close to the interface between the primary crystals and the residual glassy phase. 
It was shown in this work that the bioactive glass S53P4 can be sintered into 
amorphous and partially crystalline porous implants within a broad temperature 
interval (620°C to 1000°C). Consolidation of the S53P4 particles occurred via viscous 
flow sintering, as indicated by the substantial amount of residual glassy phase and the 
rounded particle shapes and neck formation seen throughout the whole temperature 
range studied. This implies that the sintering kinetics of the S53P4 overwhelms the 
crystallization kinetics to a certain extent. It has been reported that if the viscous flow 
is fast enough, surface crystallization does not hinder the densification process [293]. 
In addition, sintering was estimated to be nearly isotropic by using the approach by 
Boccaccini and Trusty [294]. The small deviation from the fully isotropic behavior may 
produce some shear deformation during sintering. 
Figure 29 shows the SEM images of the top surfaces with two different 
magnifications and cross sections of the implants after heat treatment for 1 h at 
various temperatures in the range 700° to 1000°C. The images of the top surfaces (the 
first two columns) were obtained using the secondary electrons, while the images of 
the cross sections (the third column) were obtained using the backscatter electrons. 
According to the µCT analysis, the total porosity of the implants decreased with 
increasing sintering temperature (STD ~ 2%): 36%, 30%, and 24% at 650°, 750°, and 
900°C, respectively. The total and open porosities of the implants were the same after 
1 h of sintering at the three temperatures, which implies that the pores are 
interconnected. No clear differences were found in the pore size distribution and the 
cumulative pore size distribution for implants sintered at the three temperatures. The 
compression strength of the implants was relatively low, but increased with the heat 
treatment temperature (from 0.7 MPa at 635°C to 10 MPa at 1000°C). To produce 
implants with greater strength, it will be necessary to optimize the time and 
temperature conditions. This was, however, outside the scope of this thesis. 
It is well known that dissolution depends in part on the surface phase composition 
and on the surface area of the sample. In partially crystalline porous implants, the 
surface area depends on the total porosity and on the surface roughness caused by 
crystallization, both of which are related to the sintering temperature. Dissolution may 
also be affected by residual tensile stress, which can develop across grain boundaries, 
or because of the mismatch between different thermal expansion coefficients of the 
glass and crystalline phases, as discussed by Nychka et al. [174]. 
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The in vitro reactivity of the sintered implants was studied by immersing the samples 
in SBF. The crystal phases which formed affected the dissolution behavior of the 
implants in SBF. The pH values showed in publication VI suggested slower initial 
dissolution for the implants sintered at 700°-800°C. The highest values were measured 
for the implants sintered at 850°C. As the pore distributions of the implants were 
almost the same, the differences in the pH were assumed to depend on changes in the 
dissolution behavior due to partial crystallization. While hydroxyapatite formed on all 
surfaces, the layer structure and thickness differed depending on the heat treatment 
temperature (Figure 30). There was better hydroxyapatite formation on amorphous 
and partially crystalline implants containing both primary and secondary crystals than 
on implants containing only primary crystals. 
 
Figure 29. SEM images of S53P4 implants after sintering for 1 h at different temperatures. From 
the left: implant surface (30x), particle surface (5kx), particle cross section (1.5kx) (publication 
VI) 
All the results suggest that S53P4 can be sintered into porous partly crystalline 
implants with adequate strength to be utilized as porous bone filler that is easily 
implantable in non-loadbearing applications. The obtained average pore size (around 
200 µm) seemed to be appropriate for tissue ingrowth. However, the obtained pore 
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morphology and interconnectivity of the pores are likely not optimal for blood vessel 
formation. The information obtained in this study can be used as guideline when 
designing sintering conditions for S53P4 for tissue engineering scaffolds manufactured 
via special methods such as replication technique. Thus, this study opens up new 
possibilities for using S53P4 to manufacture various structures, while tailoring their 
bioactivity by controlling the proportions of the different phases. 
 
Figure 30. The cross section of the porous implants after immersion for 48 h (publication VI) 
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5. Conclusions and outlook 
By combining information from various experimental conditions, a better knowledge 
of glass dissolution and the suitability of the glasses for different medical applications 
can be obtained. Chemical durability of silicate glasses were tested in water and TRIS-
buffered solution at static and dynamic conditions at different temperatures. It is 
noteworthy that in all experimental conditions, the relative dissolution order of the 
glasses was the same. 
It was also verified that the choice of immersion solution and immersion conditions 
are highly important. Furthermore, it was verified that TRIS is suitable for studying the 
dissolution behavior of glasses in a continuous flow environment. The traditional in 
vitro testing with a TRIS-buffered solution under static conditions works well with 
bioactive or with readily dissolving glasses and it is easy to follow the ion dissolution 
reactions. However, in the buffered solution no marked differences between the more 
durable glasses were observed. 
The hydrolytic resistance of the glasses was studied using ISO 719. The relative 
scale given by the standard failed to provide any relevant information when bioactive 
glasses were studied. However, the clear differences in the hydrolytic resistance values 
imply that the method could be used as a rapid test to get an overall idea of the 
biodegradability of the glasses. The standard combined with the ion concentration and 
pH measurement gives a better estimate of the hydrolytic resistance because of the 
high silicon amount released from a glass. The released silicon decreases the volume 
needed in the titrations. Furthermore, the standard procedure performed at different 
temperatures could be used to evaluate the dissolution mechanism of the glasses. 
A sensitive on-line analysis method utilizing inductively coupled plasma optical 
emission spectrometer and a flow-through micro volume pH electrode was developed 
to study the initial dissolution of bioactive glasses. This approach was found suitable 
for compositions within a large range of chemical durability. With this approach, the 
initial dissolution of all ions could be measured simultaneously and quantitatively, 
which gave a good overall idea of the initial dissolution rates for the individual ions 
and the dissolution mechanism. These types of results with glass dissolution were 
presented for the first time during the course of writing this thesis. Furthermore, the 
experimental parameters could be easily adjusted for various types of dissolution 
measurements. The method was shown to be sensitive for rapid screening of the 
dissolution mechanism of glasses in highly different experimental conditions. The 
experimental conditions clearly affected the initial dissolution rate of glasses, and in 
some cases the mechanism was changed. 
Based on the initial dissolution patterns obtained with the novel approach using 
TRIS, the glasses could be divided into four distinct categories. The initial dissolution 
patterns of glasses correlated well with the anticipated bioactivity. Moreover, the 
normalized surface-specific mass loss rates and the different in vivo models and the 
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actual in vivo data correlated well. The results suggest that this type of approach can be 
used for pre-screening the suitability of novel glass compositions for future clinical 
applications, and furthermore shed light on possible bioactivity. 
To further strengthen the implications given by the novel approach, information 
about surface property changes would be relevant. Consequently, sensitive analysis 
methods applied to the surface during and after the dissolution test would be of 
interest. Furthermore, the method should be tested with known bioactive materials to 
verify whether the observed trend fits other materials as well. The initial dissolution 
data could also benefit modeling work in the future. However, parameters like initial 
density and surface area need to be more accurately defined. As the method also gave 
implications regarding the glass structure, this path would be interesting to elaborate 
further by combining information from MAS-NMR studies. The next step for testing 
the dissolution of materials would be to test the influence of surface area and 
morphology. In addition, it would be of interest to evaluate how the initial dissolution 
of putty applications varies with the gel and glass matrix and how different 
pretreatments affect the initial dissolution.   
Engineering type T-T-T curves for glasses 1-98 and 13-93 were established. A good 
correlation between the values reported for crystallization of the particles and the 
obtained T-T-T curve for 1-98 was observed. The information gained is essential in 
manufacturing amorphous porous implants or for drawing of continuous fibers of the 
glasses. Although both glasses can be hot worked to amorphous products at carefully 
controlled conditions, 1-98 showed one magnitude greater nucleation and crystal 
growth rate than 13-93. Thus, 13-93 is better suited than 1-98 for working processes 
which require long residence times at high temperatures. 
It was also shown that amorphous and partially crystalline porous implants can be 
sintered from bioactive glass S53P4. Surface crystallization of S53P4, forming 
Na2O∙CaO∙2SiO2, was observed to start at 650°C, and secondary crystals of 
Na2Ca4(PO4)2SiO4 were detected at higher temperatures, from 850°C to 1000°C. The 
crystal phases which formed affected the dissolution behavior of the implants in 
simulated body fluid. This study opens up new possibilities for using S53P4 to 
manufacture various structures, while tailoring their bioactivity by controlling the 
proportions of the different phases. 
Knowledge of both the dissolution behavior and hot-working properties is of 
utmost importance when glasses are developed for different clinical applications. 
Understanding the in vitro dissolution rate of glasses provides a preliminary 
approximation of the behavior of the glasses in vivo. The results obtained in this thesis 
give valuable additional information and tools to the state-of-the-art for designing 
glasses with respect to future clinical applications. In addition, the novel on-line 
analysis approach provides an excellent opportunity to further enhance our knowledge 
of glass behavior in simulated body conditions. 
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7. Appendix 
Definitions  
(compiled from  [89, 246, 295]) 
allograft Tissue that is taken from one person's body and grafted to another person.  
amorphous having no definite form  
angiogenesis The process of developing new blood vessels  
autograft A tissue or an organ grafted into a new position in or on the body of the same 
individual 
 
bio- life; living (prefix)  
bioactive pertaining to a material that displays bioactivity  
bioactive glass any glass or glass ceramic that display characteristics of bioactivity 
amorphous solid that is not intrinsically adhesive and that is capable of 
forming a cohesive bond with both hard and soft tissue when exposed to 
appropriate in vivo or in vitro environments, such as simulated body fluid or 
tris-hydroxymethylaminomethane buffer, by developing a surface layer of 
hydroxycarbonate apatite by release of ionic species from the bulk material 
(ASTM)  
 
bioactive material material which has been designed to induce specific biological activity 
biomaterial that is designed to elicit or modulate biological activity 
 
bioactivity phenomena by which a biomaterial elicits or modulates biological activity  
bioadsorbable capable of being degraded or dissolved and subsequently metabolized within 
an organism 
 
bioceramic any ceramic; glass or glass ceramic that is used as biomaterial 
ceramic that upon implantation is transformed into less soluble minerals  
 
biocompatibility See chapter 2.1  
Bioglass 45S5 (wt %) 24.5 Na2O, 24.5 CaO, 6.0 P2O5, and 45.0 SiO2, 
(registered trademark University of Florida, Gainesville)  
 
bioinert term used loosely to characterize materials that are considered inert in a 
biological environment 
 
biomaterial See Table 1  
bone bonding the establishment, by physico-chemical processes, of continuity between an 
implant and bone matrix 
 
cancelleous bone any bone having a lattice-like, spongy structure  
clinical relating to the observation and treatment of disease in patient, as opposed to 
theoretical and experimental investigations 
 
composite material structural material made of two or more distinctly different materials, where 
each component contributes positively to the final properties  
 
corrosion see 2.2.3  
cortical bone thin outer layer of compact bone, made up of lamellated rings of collagen 
fibers 
 
craniofacial relating to the cranium and the face  
cytotoxic able to kill or damage cells  
degradation product product of a material, either particulate or molecular, that is generated by 
degradation of that material 
 
devitrification crystallization of an amorphous substance  
diffusion spontaneous movement of molecules or other particles in the solution, owing 
to their random thermal motion, to reach uniform concentration throughout 
the solvent, the process requiring no addition of energy to the system 
 
glass durability see 2.2.2  
hydrolytic resistance see 2.2.2  
implant 1.medical device made from one or more biomaterials that is intentionally 
placed within the body either totally or partially buried beneath an epithelial 
surface 
2.medical device that is placed into a surgically or naturally formed cavity of 
the human body it is intended to remain there of a period of 30 days or more 
3.to insert any object into a surgically or naturally formed site in the body, 
with the intention of leaving it there after the procedure is complete  
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in vitro literally “in glass” or “test tube”; used to refer to processes that are carried out 
outside the living body, usually in the laboratory, as distinguished from in vivo 
 
in vivo within a living body  
ion exchange exchange of ions of the same charge between a solution (usually aqueous) and 
a solid in contact with it 
 
ion release term used to describe the process in which a material interacts with its 
environment by means of evolution of ions into that environment 
 
isotropy the ability of materials to display similar mechanical properties in all directions 
regardless of directions of applied stress, applicable also for other material 
properties 
 
laminar flow streamline flow of a fluid in which the fluid moves in layers without 
fluctuations or turbulence so that successive particles passing the same point 
have the same velocity  
 
leaching extraction of soluble components of a solid material or mixture by immersion 
in a solvent or by percolating a solvent through it 
 
nucleation initiation of processes, such as crystallization or fracture of materials   
osteoblast bone-forming cell  
osteoclast large multinuclear cell associated with absorption and removal of bone  
osteogenesis The process of formation of bone  
osteoinduction act or process stimulating osteogenesis  
resorbable capable of being resorbed into the body  
scaffold in tissue-engineering, the porous structure, usually polymeric, which serves as 
a substrate and guide for tissue-regeneration 
 
simulated body fluid an acellular simulated body fluid that has inorganic ion concentrations similar 
to those of human extracellular fluid 
 
sintering process in which particles of a substance are compressed, usually at elevated 
temperature, to form a solid object 
 
solid solution arrangement of atoms or molecules of different species within the same 
crystal lattice 
 
tissue engineering 1. the persuasion of the body to heal itself, through a delivery to the 
appropriate sites of molecular signals, cells, and supporting structures 
2. application of scientific principles to the design, construction, modification, 
growth, and maintenance of living tissues 
3. the application of the principles and methods of engineering and life 
sciences towards fundamental understanding of structure/function 
relationships in normal and pathological mammalian tissues and the 
development of biological substitutes to restore, maintain, or improve 
functions. 
4. an emerging discipline that applies engineering principles to create devices 
for the study, restoration, modification, and assembly of functional tissues 
from native or synthetic sources 
5. Generation of new tissue using living cells, optimally patient’s own cells, as 
building blocks, coupled with degradable materials as scaffolds  
 
weathering see 2.2.2  
xenograft Tissue that is transplanted from one species to another (for example from 
pigs to humans) 
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